10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2016

OR

[   ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 001-12019

QUAKER CHEMICAL CORPORATION

(Exact name of Registrant as specified in its charter)

Pennsylvania	23-0993790
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

One Quaker Park, 901 E. Hector Street, Conshohocken, Pennsylvania	19428 – 2380
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: 610-832-4000

Not Applicable

Former name, former address and former fiscal year, if changed since last report.

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  [X]      No  [  ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).            Yes    [X]     No [  ]

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [X]	Accelerated filer  [  ]
Non-accelerated filer  [  ](Do not check if smaller reporting company)	Smaller reporting company [  ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  [  ]    No  [X] 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Number of Shares of Common Stock Outstanding on March 31, 2016 13,236,040

QUAKER CHEMICAL CORPORATION AND CONSOLIDATED SUBSIDIARIES

		Page
PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements (unaudited)
	Condensed Consolidated Statements of Income for the Three Months Ended March 31, 2016 and March 31, 2015	2
	Condensed Consolidated Statements of Comprehensive Income for the Three Months Ended March 31, 2016 and March 31, 2015	3
	Condensed Consolidated Balance Sheets at March 31, 2016 and December 31, 2015	4
	Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2016 and March 31, 2015	5
	Notes to Condensed Consolidated Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	20
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	26
Item 4.	Controls and Procedures	27
PART II.	OTHER INFORMATION	28
Item 1.	Legal Proceedings	28
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	28
Item 6.	Exhibits	29
Signatures		29

1

PART I

FINANCIAL INFORMATION

Item 1.                        Financial Statements (Unaudited).

Quaker Chemical Corporation

Condensed Consolidated Statements of Income

(Dollars in thousands, except per share data)

		Unaudited
		Three Months Ended March 31,
		2016		2015
Net sales		$	178,077	$	181,330
Cost of goods sold			110,202		115,002
Gross profit			67,875		66,328
Selling, general and administrative expenses			48,641		48,464
Operating income			19,234		17,864
Other income (expense), net			706		(194)
Interest expense			(741)		(587)
Interest income			348		320
Income before taxes and equity in net income of associated companies			19,547		17,403
Taxes on income before equity in net income of associated companies			6,305		5,359
Income before equity in net income of associated companies			13,242		12,044
Equity in net income (loss) of associated companies			102		(1,437)
Net income			13,344		10,607
Less: Net income attributable to noncontrolling interest			398		229
Net income attributable to Quaker Chemical Corporation		$	12,946	$	10,378
Per share data:
	Net income attributable to Quaker Chemical Corporation common shareholders – basic	$	0.98	$	0.78
	Net income attributable to Quaker Chemical Corporation common shareholders – diluted	$	0.98	$	0.78
	Dividends declared	$	0.32	$	0.30

The accompanying notes are an integral part of these condensed consolidated financial statements.

2

Quaker Chemical Corporation

Condensed Consolidated Statements of Comprehensive Income

(Dollars in thousands)

			Unaudited
			Three Months Ended March 31,
				2016		2015
Net income			$	13,344	$	10,607
Other comprehensive income (loss), net of tax
	Currency translation adjustments			4,733		(11,083)
	Defined benefit retirement plans			187		2,478
	Unrealized gain on available-for-sale securities			456		70
		Other comprehensive income (loss)		5,376		(8,535)
Comprehensive income				18,720		2,072
Less: Comprehensive income attributable to noncontrolling interest				(460)		(259)
Comprehensive income attributable to Quaker Chemical Corporation			$	18,260	$	1,813

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

Quaker Chemical Corporation

Condensed Consolidated Balance Sheets

(Dollars in thousands, except par value and share amounts)

			Unaudited
			March 31,  2016		December 31, 2015
ASSETS
Current assets
	Cash and cash equivalents		$	94,374	$	81,053
	Accounts receivable, net			188,218		188,297
	Inventories
		Raw materials and supplies		37,322		36,876
		Work-in-process and finished goods		40,898		38,223
	Prepaid expenses and other current assets			20,537		21,404
		Total current assets		381,349		365,853
Property, plant and equipment, at cost				236,811		231,164
	Less accumulated depreciation			(149,576)		(143,545)
		Net property, plant and equipment		87,235		87,619
Goodwill				80,003		79,111
Other intangible assets, net				72,464		73,287
Investments in associated companies				21,194		20,354
Non-current deferred tax assets				19,916		23,468
Other assets				32,405		32,218
		Total assets	$	694,566	$	681,910
LIABILITIES AND EQUITY
Current liabilities
	Short-term borrowings and current portion of long-term debt		$	645	$	662
	Accounts and other payables			69,748		71,543
	Accrued compensation			13,626		19,166
	Accrued restructuring			5,969		6,303
	Other current liabilities			25,397		26,881
		Total current liabilities		115,385		124,555
Long-term debt				97,620		81,439
Non-current deferred tax liabilities				11,071		11,400
Other non-current liabilities				78,964		83,273
		Total liabilities		303,040		300,667
Commitments and contingencies (Note 15)
Equity
	Common stock $1 par value; authorized 30,000,000 shares; issued and
		outstanding 2016 – 13,236,040 shares; 2015 – 13,288,113 shares		13,236		13,288
	Capital in excess of par value			107,950		106,333
	Retained earnings			329,684		326,740
	Accumulated other comprehensive loss			(68,002)		(73,316)
		Total Quaker shareholders’ equity		382,868		373,045
Noncontrolling interest				8,658		8,198
Total equity				391,526		381,243
		Total liabilities and equity	$	694,566	$	681,910

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

Quaker Chemical Corporation

Condensed Consolidated Statements of Cash Flows

(Dollars in thousands)

				Unaudited
				For the Three Months Ended
				March 31,
				2016		2015
Cash flows from operating activities
	Net income			$	13,344	$	10,607
	Adjustments to reconcile net income to net cash provided by operating activities:
		Depreciation			3,157		3,071
		Amortization			1,777		1,627
		Equity in undistributed earnings of associated companies, net of dividends			(27)		1,437
		Deferred compensation and other, net			980		1,091
		Stock-based compensation			1,798		1,685
		Gain on disposal of property, plant and equipment and other assets			(20)		(21)
		Insurance settlement realized			(279)		(115)
		Pension and other postretirement benefits			(2,685)		10
	Increase (decrease) in cash from changes in current assets and current
			liabilities, net of acquisitions:
		Accounts receivable			2,602		3,428
		Inventories			(1,800)		(2,584)
		Prepaid expenses and other current assets			1,183		(2,634)
		Accounts payable and accrued liabilities			(8,647)		(9,516)
		Change in restructuring liabilities			(509)		—
			Net cash provided by operating activities		10,874		8,086
Cash flows from investing activities
		Investments in property, plant and equipment			(2,172)		(2,414)
		Payments related to acquisitions, net of cash acquired			(1,384)		528
		Proceeds from disposition of assets			26		80
		Insurance settlement interest earned			8		10
		Change in restricted cash, net			271		105
			Net cash used in investing activities		(3,251)		(1,691)
Cash flows from financing activities
		Proceeds from long-term debt			14,687		—
		Repayment of long-term debt			(159)		(1,327)
		Dividends paid			(4,243)		(3,990)
		Stock options exercised, other			(253)		(50)
		Payments for repurchase of common stock			(5,859)		—
		Excess tax benefit related to stock option exercises			104		287
			Net cash provided by (used in) financing activities		4,277		(5,080)
Effect of exchange rate changes on cash					1,421		(1,708)
		Net increase (decrease) in cash and cash equivalents			13,321		(393)
		Cash and cash equivalents at beginning of period			81,053		64,731
		Cash and cash equivalents at end of period		$	94,374	$	64,338

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements

(Dollars in thousands, except share and per share amounts, unless otherwise stated)

(Unaudited)

Note 1 – Condensed Financial Information

The condensed consolidated financial statements included herein are unaudited and have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial reporting and the United States Securities and Exchange Commission (“SEC”) regulations.  Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations.  In the opinion of management, the financial statements reflect all adjustments (consisting only of normal recurring adjustments, except certain material adjustments, as discussed below) which are necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods.  The results for the three months ended March 31, 2016 are not necessarily indicative of the results to be expected for the full year.  These financial statements should be read in conjunction with the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2015.  During the first quarter of 2016, the Company revised its Condensed Consolidated Balance Sheet for December 31, 2015, reducing non-current deferred tax assets and non-current deferred tax liabilities by $3.6 million each, to correct for offsetting deferred tax balances within related taxing jurisdictions.  The Company considers such revision to be immaterial and the revision had no impact on reported equity, net income or net cash provided by operating activities. 

Venezuela’s economy has been considered hyper inflationary under U.S. GAAP since 2010, at which time the Company’s Venezuela equity affiliate, Kelko Quaker Chemical, S.A. (“Kelko Venezuela”), changed its functional currency from the bolivar fuerte (“BsF”) to the U.S. dollar.  Accordingly, all gains and losses resulting from the remeasurement of Kelko Venezuela’s monetary assets and liabilities to published exchange rates are required to be recorded directly to the Condensed Consolidated Statement of Income.  As of December 31, 2014, there were three legally available exchange rates in Venezuela, the CADIVI (or the official rate, 6.3 BsF per U.S. dollar), the SICAD I and the SICAD II.  Kelko Venezuela had access to the CADIVI for imported goods, had not been invited to participate in any SICAD I auctions and had limited access to the SICAD II mechanism.  Accordingly, the Company measured its equity investment and other related assets with Kelko Venezuela at the CADIVI exchange rate at December 31, 2014.  During the three months ended March 31, 2015, the Venezuela government announced changes to its foreign exchange controls.  There continued to be three exchange mechanisms, however, they consisted of the CADIVI, a combined SICAD I and SICAD II auction mechanism (the “SICAD”) and a newly created, marginal currency system (the “SIMADI”).  In light of the first quarter of 2015 changes to Venezuela’s foreign exchange controls and the on-going economic challenges in Venezuela, the Company re-assessed Kelko Venezuela’s access to U.S. dollars, the impact on the operations of Kelko Venezuela, and the impact on the Company’s equity investment and other related assets, which resulted in revaluing its equity investment in Kelko Venezuela and other related assets to the SIMADI exchange rate of approximately 193 BsF per U.S. dollar as of March 31, 2015.  This resulted in a charge of $2.8 million, or $0.21 per diluted share, recorded in the three months ended March 31, 2015.  As of December 31, 2015, the Company’s equity investment in Kelko Venezuela was $0.2 million, and continued to be valued at the SIMADI exchange rate, which was approximately 198 BsF per U.S. dollar.

During the three months ended March 31, 2016, the Venezuela government announced further changes to its foreign exchange controls, including eliminating the CADIVI, SICAD and SIMADI exchange rate mechanisms and replacing them with a new dual foreign exchange rate system.  The Company understands that the new dual foreign exchange rate system now consists of a protected “DIPRO” exchange rate, with a rate fixed at 10 Bsf per U.S. dollar and, also, a floating supplementary market exchange rate known as the “DICOM.”  The DIPRO rate will only be available for payment of certain imports of essential goods in the food and health sectors while the DICOM will govern all other transactions not covered by DIPRO.  As of March 31, 2016, the published rate for the DICOM was approximately 273 BsF per U.S. dollar.  In light of these changes to the foreign exchange controls during the three months ended March 31, 2016, the Company again re-assessed Kelko Venezuela’s access to U.S. dollars, the impact on the operations of Kelko Venezuela, and the impact on the Company’s equity investment and other related assets.  The Company does not believe it currently has access to the DIPRO and, therefore, believes the DICOM is currently the exchange rate system available to Kelko Venezuela, which resulted in a currency conversion charge of $0.1 million, or $0.01 per diluted share, during the three months ended March 31, 2016.  As of March 31, 2016, the Company’s equity investment in Kelko Venezuela was $0.2 million, valued at the DICOM exchange rate. 

As part of the Company’s chemical management services, certain third-party product sales to customers are managed by the Company.  Where the Company acts as the principal, revenue is recognized on a gross reporting basis at the selling price negotiated with customers.  Where the Company acts as an agent, such revenue is recorded using net reporting of service revenue, at the amount of the administrative fee earned by the Company for ordering the goods.  Third-party products transferred under arrangements resulting in net reporting totaled $11.1 million and $11.9 million for the three months ended March 31, 2016 and 2015, respectively.

6

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements - Continued

(Dollars in thousands, except share and per share amounts, unless otherwise stated)

(Unaudited)

Note 2 – Recently Issued Accounting Standards

The Financial Accounting Standards Board ("FASB") issued an accounting standard update in March 2016 involving several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, use of a forfeiture rate, and classification on the statement of cash flows.  The guidance within this accounting standard update is effective for annual and interim periods beginning after December 15, 2016.  Early adoption is permitted, however, if early adoption is elected, all amendments in the update must be adopted in the same period.  When adopted, application of the guidance will vary based on each aspect of the update; including on a retrospective, modified retrospective or prospective basis.  The Company has not early adopted and is currently evaluating the potential impact of this guidance and considering the appropriate implementation strategy. 

The FASB issued an accounting standard update in February 2016 regarding the accounting and disclosure for leases.  Specifically, the update will require entities that lease assets to recognize the assets and liabilities for the rights and obligations created by those leases on the balance sheet, in most instances.  The guidance within this accounting standard update is effective for annual and interim periods beginning after December 15, 2018, and should be applied on a modified retrospective basis for the reporting periods presented.  Early adoption is permitted.  The Company has not early adopted and is currently evaluating the potential impact of this guidance and considering the appropriate implementation strategy.

The FASB issued an accounting standard update in November 2015 regarding the classification of deferred taxes on the balance sheet.  The update requires that all deferred tax assets and liabilities, along with any related valuation allowance, be classified as noncurrent on the balance sheet.  The update does not change the existing requirement that only permits offsetting within a jurisdiction.  The guidance within this accounting standard update is effective for annual and interim periods beginning after December 15, 2016, and may be applied either prospectively, for all deferred tax assets and liabilities, or retrospectively.  Early adoption is permitted.  The Company has not early adopted.  Adoption of the guidance will not have an impact on the Company’s earnings or cash flow but will result in a balance sheet reclassification between current and long-term assets and liabilities.

The FASB issued an accounting standard update in July 2015 regarding simplifying the measurement of inventory.  The guidance is applicable for entities that measure inventory using the FIFO or average cost methods.  Specifically, the update requires that inventory be measured at lower of cost or net realizable value.  Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.  The amendments in this update are effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years.  This guidance should be applied prospectively with early adoption permitted.  As of March 31, 2016, the Company has elected to early adopt this guidance without a material impact.

The FASB issued an accounting standard update in May 2015 regarding the required disclosures for entities that elect to measure the fair value of certain investments using the net asset value per share (or its equivalent) practical expedient in accordance with the fair value measurement authoritative guidance.  The update removes the requirement to categorize within the fair value hierarchy, and also limits the requirement to make certain other disclosures, for all such investments.  The amendments in this update are effective for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years, and should be applied on a retrospective basis for the periods presented.  Early adoption was permitted.  As of March 31, 2016, the Company has adopted this guidance without a material impact.

The FASB issued an accounting standard update in April 2015 regarding the presentation of debt issuance costs on the balance sheet.  The update requires capitalized debt issuance costs be presented on the balance sheet as a reduction to debt, rather than recorded as a separate asset.  The amendments in this update are effective for annual and interim periods beginning after December 15, 2015 and should be applied on a retrospective basis for the periods presented.  Early adoption was permitted.  Also, in June 2015, the SEC staff announced that the guidance within this accounting standard update was not applicable to revolving debt arrangements or credit facilities.  As of March 31, 2016, the Company has adopted this guidance without a material impact.

The FASB issued an accounting standard update in May 2014 regarding the accounting for and disclosure of revenue recognition.  Specifically, the update outlined a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers, which will be common to both U.S. GAAP and International Financial Reporting Standards (“IFRS”).  The guidance was effective for annual and interim periods beginning after December 15, 2016, and allowed for full retrospective adoption of prior period data or a modified retrospective adoption.  Early adoption was not permitted.  In August 2015, the FASB issued an accounting standard update to delay the effective date of the new revenue standard by one year, or, in other words, to be effective for annual and interim periods beginning after December 15, 2017.  Entities will be permitted to adopt the new revenue standard early but not before the original effective date.  In March 2016, the FASB issued an accounting standard update to clarify the implementation guidance on principal versus agent considerations.  In April 2016, the FASB issued an accounting standard update to clarify the identification of performance obligations and the licensing implementation guidance, while retaining the related principles for those

7

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements - Continued

(Dollars in thousands, except share and per share amounts, unless otherwise stated)

(Unaudited)

areas.  The amendments in these 2016 updates do not change the core principle of the previously issued guidance in May 2014.  The Company is currently evaluating the potential impact of the new revenue recognition guidance and considering the appropriate implementation strategy.

Note 3 – Restructuring and Related Activities

In response to continued weak economic conditions and market declines in many regions, Quaker’s management approved a global restructuring plan (the “2015 Program”) in the fourth quarter of 2015 to reduce its operating costs.  The 2015 Program includes the re-organization of certain commercial functions, the closure of certain distribution, lab and administrative offices, and other related severance charges.  In addition to these actions, the Company made a decision to make available for sale certain technology of one of its existing businesses, which also resulted in employee severance and $0.3 million of intangible assets being reclassified to other current assets as of December 31, 2015.  During the three months ended March 31, 2016, there has been no further update and the intangible assets continue to be available for sale and included in other current assets.

The 2015 Program includes provisions for the reduction of total headcount by approximately 65 employees globally.  Employee separation benefits varied depending on local regulations within certain foreign countries and included severance and other benefits.  The Company continues to expect to substantially complete all of the initiatives under the 2015 Program during 2016 and expects settlement of these charges to occur primarily in 2016 as well.  The Company did not incur additional restructuring expenses in connection with the 2015 Program during the first quarter of 2016, and, at this time, the Company does not expect material, additional restructuring expenses beyond customary and routine adjustments to initial estimates for employee separation benefits.   

Restructuring activity recognized in connection with the 2015 Program is as follows:

		North						South
		America		EMEA		Asia/Pacific		America		Total
Accrued restructuring as of
December 31, 2015		$	1,867	$	4,265	$	135	$	36	$	6,303
	Cash payments		(284)		(54)		(132)		(39)		(509)
	Currency translation adjustments		—		175		(3)		3		175
Accrued restructuring as of
March 31, 2016		$	1,583	$	4,386	$	—	$	—	$	5,969

Note 4 – Business Segments

The Company’s reportable operating segments are organized by geography as follows: (i) North America, (ii) Europe, Middle East and Africa (“EMEA”), (iii) Asia/Pacific and (iv) South America.  Operating earnings, excluding indirect operating expenses, for the Company’s reportable operating segments are comprised of revenues less costs of goods sold and selling, general and administrative expenses (“SG&A”) directly related to the respective region’s product sales.  The indirect operating expenses consist of SG&A related expenses that are not directly attributable to the product sales of each respective reportable operating segment.  Other items not specifically identified with the Company’s reportable operating segments include interest expense, interest income, license fees from non-consolidated affiliates and other income (expense).

8

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements - Continued

(Dollars in thousands, except share and per share amounts, unless otherwise stated)

(Unaudited)

The following table presents information about the performance of the Company’s reportable operating segments for the three months ended March 31, 2016 and 2015:

		Three Months Ended
		March 31,
		2016		2015
Net sales
	North America	$	82,372	$	83,002
	EMEA		47,649		43,185
	Asia/Pacific		41,512		45,000
	South America		6,544		10,143
Total net sales		$	178,077	$	181,330
Operating earnings, excluding indirect operating expenses
	North America	$	18,632	$	17,825
	EMEA		8,053		6,571
	Asia/Pacific		11,048		10,434
	South America		(315)		1,252
Total operating earnings, excluding indirect operating expenses			37,418		36,082
Indirect operating expenses			(16,407)		(16,591)
Amortization expense			(1,777)		(1,627)
Consolidated operating income			19,234		17,864
Other income (expense), net			706		(194)
Interest expense			(741)		(587)
Interest income			348		320
Consolidated income before taxes and equity in net income of associated companies		$	19,547	$	17,403

Inter-segment revenues for the three months ended March 31, 2016 and 2015 were $1.8 million and $2.0 million for North America, $3.9 million and $4.8 million for EMEA, $0.3 million and $0.1 million for Asia/Pacific, respectively, and less than $0.1 million for South America in both periods.  However, all inter-segment transactions have been eliminated from each reportable operating segment’s net sales and earnings for all periods presented above.

Note 5 – Stock-Based Compensation

The Company recognized the following stock-based compensation expense in SG&A in its Condensed Consolidated Statements of Income for the three months ended March 31, 2016 and 2015:

	Three Months Ended
	March 31,
	2016		2015
Stock options	$	201	$	185
Nonvested stock awards and restricted stock units		848		752
Employee stock purchase plan		23		18
Non-elective and elective 401(k) matching contribution in stock		689		699
Director stock ownership plan		37		31
Total stock-based compensation expense	$	1,798	$	1,685

The Company’s estimated taxes payable as of March 31, 2016 and 2015, respectively, were sufficient to fully recognize $0.1 million and $0.3 million of excess tax benefits related to stock option exercises as cash inflows from financing activities in its Condensed Consolidated Statements of Cash Flows, for the three months ended March 31, 2016 and 2015, respectively.

9

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements - Continued

(Dollars in thousands, except share and per share amounts, unless otherwise stated)

(Unaudited)

Stock option activity under all plans is as follows:

					Weighted
			Weighted		Average
			Average		Remaining	Aggregate
		Number of	Exercise Price		Contractual	Intrinsic
		Options	(per option)		Term (years)	Value
Options outstanding at December 31, 2015		99,671	$	71.73
	Options granted	67,444		72.12
Options outstanding at March 31, 2016		167,115	$	71.89	5.7	$	2,317
Options expected to vest at March 31, 2016		103,040	$	75.82	6.4	$	1,027
Options exercisable at March 31, 2016		64,075	$	65.57	4.4	$	1,290

There were no options exercised during the three months ended March 31, 2016.  The total intrinsic value of options exercised during the three months ended March 31, 2015 was $0.2 million.  Intrinsic value is calculated as the difference between the current market price of the underlying security and the strike price of a related option.

A summary of the Company’s outstanding stock options at March 31, 2016 is as follows: 

						Weighted
						Average	Weighted			Weighted
					Number	Remaining	Average		Number	Average
Range of					of Options	Contractual	Exercise Price		of Options	Exercise Price
Exercise Prices					Outstanding	Term (years)	(per option)		Exercisable	(per option)
$	—	-	$	10.00	—	—	$	—	—	$	—
$	10.01	-	$	20.00	2,367	0.8		18.82	2,367		18.82
$	20.01	-	$	30.00	—	—		—	—		—
$	30.01	-	$	40.00	6,317	2.9		38.13	6,317		38.13
$	40.01	-	$	50.00	—	—		—	—		—
$	50.01	-	$	60.00	21,055	3.9		58.26	21,055		58.26
$	60.01	-	$	70.00	—	—		—	—		—
$	70.01	-	$	80.00	101,230	6.2		72.57	22,281		73.47
$	80.01	-	$	90.00	36,146	5.9		87.30	12,055		87.30
					167,115	5.7		71.89	64,075		65.57

As of March 31, 2016, unrecognized compensation expense related to options granted during 2014, 2015, and 2016 was $0.2 million, $0.5 million, and $1.0 million, respectively.

During the first quarter of 2016, the Company granted stock options under its LTIP plan that are subject only to time vesting over a three-year period.  For the purposes of determining the fair value of stock option awards, the Company uses the Black-Scholes option pricing model and the assumptions set forth in the table below:

	2016
Number of options granted	67,444
Dividend yield	1.49	%
Expected volatility	28.39	%
Risk-free interest rate	1.08	%
Expected term (years)	4.0

Less than $0.1 million of expense was recorded on these options during the three months ended March 31, 2016.  The fair value of these awards is amortized on a straight-line basis over the vesting period of the awards.

10

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements - Continued

(Dollars in thousands, except share and per share amounts, unless otherwise stated)

(Unaudited)

Activity of nonvested shares granted under the Company’s LTIP plan is shown below:

			Weighted
			Average Grant
		Number of	Date Fair Value
		Shares	(per share)
Nonvested awards, December 31, 2015		113,910	$	72.91
	Granted	23,661	$	72.22
	Vested	(17,785)	$	58.97
Nonvested awards, March 31, 2016		119,786	$	74.84

The fair value of the nonvested stock is based on the trading price of the Company’s common stock on the date of grant.  The Company adjusts the grant date fair value for expected forfeitures based on historical experience for similar awards.  As of March 31, 2016, unrecognized compensation expense related to these awards was $4.5 million to be recognized over a weighted average remaining period of 2.0 years.

Activity of nonvested restricted stock units granted under the Company’s LTIP plan is shown below:

			Weighted
			Average Grant
		Number of	Date Fair Value
		Units	(per unit)
Nonvested awards, December 31, 2015		6,174	$	74.14
	Granted	1,841	$	72.12
	Vested	(1,418)	$	58.26
Nonvested awards, March 31, 2016		6,597	$	76.99

The fair value of the nonvested restricted stock units is based on the trading price of the Company’s common stock on the date of grant.  The Company adjusts the grant date fair value for expected forfeitures based on historical experience for similar awards.  As of March 31, 2016, unrecognized compensation expense related to these awards was $0.2 million to be recognized over a weighted average remaining period of 2.1 years.

Employee Stock Purchase Plan

In 2000, the Board adopted an Employee Stock Purchase Plan (“ESPP”) whereby employees may purchase Company stock through a payroll deduction plan.  Purchases are made from the plan and credited to each participant’s account at the end of each month (the “Investment Date”).  The purchase price of the stock is 85% of the fair market value on the Investment Date.  The plan is compensatory and the 15% discount is expensed on the Investment Date.  All employees, including officers, are eligible to participate in this plan.  A participant may withdraw all uninvested payment balances credited to a participant’s account at any time.  An employee whose stock ownership of the Company exceeds five percent of the outstanding common stock is not eligible to participate in this plan.

2013 Director Stock Ownership Plan

In 2013, the Company adopted the 2013 Director Stock Ownership Plan (the “Plan”), to encourage the Directors to increase their investment in the Company, which was approved at the Company’s May 2013 shareholders’ meeting.  The Plan authorizes the issuance of up to 75,000 shares of Quaker common stock in accordance with the terms of the Plan in payment of all or a portion of the annual cash retainer payable to each of the Company’s non-employee directors in 2013 and subsequent years during the term of the Plan.  Under the Plan, each director who, on May 1 of the applicable calendar year, owns less than 400% of the annual cash retainer for the applicable calendar year, divided by the average of the closing price of a share of Quaker Common Stock as reported by the composite tape of the New York Stock Exchange for the previous calendar year (the “Threshold Amount”), is required to receive 75% of the annual cash retainer in Quaker common stock and 25% of the retainer in cash, unless the director elects to receive a greater percentage of Quaker common stock (up to 100%) of the annual cash retainer for the applicable year.  Each director who owns more than the Threshold Amount may elect to receive common stock in payment of a percentage (up to 100%) of the annual cash retainer.  The annual retainer is $0.1 million and the retainer payment date is June 1.

11

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements - Continued

(Dollars in thousands, except share and per share amounts, unless otherwise stated)

(Unaudited)

Note 6 – Pension and Other Postretirement Benefits

The components of net periodic benefit cost for the three months ended March 31, 2016 and 2015 are as follows:

	Three Months Ended March 31,
					Other
	Pension Benefits				Postretirement Benefits
		2016		2015		2016		2015
Service cost	$	670	$	773	$	4	$	5
Interest cost		1,111		1,262		39		50
Expected return on plan assets		(1,344)		(1,402)		—		—
Actuarial loss amortization		808		881		15		26
Prior service cost amortization		(25)		(26)		—		—
Net periodic benefit cost	$	1,220	$	1,488	$	58	$	81

As of December 31, 2015, the Company elected to use a split discount rate (spot-rate approach) for the U.S. plans and certain foreign plans, which includes the method used to estimate the service and interest components of net periodic benefit cost for pension and other postretirement benefits beginning in the three months ended March 31, 2016.  This change resulted in a decrease in the service and interest components for pension cost in the three months ended March 31, 2016 compared to the three months ended March 31, 2015.  Historically, the Company estimated service and interest cost components utilizing a single weighted-average discount rate derived from a specific yield curve used to measure the benefit obligation at the beginning of the period.  Under the spot-rate approach, service and interest cost components have been estimated based on the application of the spot rates on a given yield curve at each future year to each plan's projected cash flows to measure the benefit obligation at the beginning of the period.  We have made this change to provide a more precise measurement of service and interest costs by improving the correlation between projected benefit cash flows and the corresponding spot yield curve rates.  We have accounted for this as a change in accounting estimate and, accordingly, have accounted for it prospectively.

Employer Contributions

The Company previously disclosed in its financial statements for the year ended December 31, 2015, that it expected to make minimum cash contributions of $7.5 million to its pension plans and $0.5 million to its other postretirement benefit plan in 2016.  As of March 31, 2016, $3.6 million and $0.2 million of contributions have been made to the Company’s pension plans and its postretirement benefit plans, respectively.

Note 7 – Other Income (Expense), Net

The components of other income (expense), net for the three months ended March 31, 2016 and 2015 are as follows:

	Three Months Ended
	March 31,
	2016		2015
Income from third party license fees	$	272	$	254
Foreign exchange gains (losses), net		312		(594)
Gain on fixed asset disposals, net		5		52
Non-income tax refunds and other related credits		21		69
Other non-operating income		124		72
Other non-operating expense		(28)		(47)
Total other income (expense), net	$	706	$	(194)

Note 8 – Income Taxes and Uncertain Income Tax Positions

The Company’s three months ended March 31, 2016 effective tax rate was 32.3% compared to three months ended March 31, 2015 effective tax rate of 30.8%.  The increase in the first quarter of 2016 effective tax rate was primarily due to the Company recording earnings in one of its subsidiaries at a statutory tax rate of 25% during the first quarter of 2016, while it awaits recertification of a concessionary 15% tax rate, which was available to the Company during the first quarter of 2015.

As of March 31, 2016, the Company’s cumulative liability for gross unrecognized tax benefits was $11.4 million.  At December 31, 2015, the Company’s cumulative liability for gross unrecognized tax benefits was $11.0 million.

12

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements - Continued

(Dollars in thousands, except share and per share amounts, unless otherwise stated)

(Unaudited)

The Company continues to recognize interest and penalties associated with uncertain tax positions as a component of taxes on income before equity in net income of associated companies in its Condensed Consolidated Statements of Income.  The Company recognized ($0.1) million for interest and less than ($0.1) million for penalties in its Condensed Consolidated Statement of Income for the three months ended March 31, 2016, and recognized ($0.2) million for interest and $0.1 million for penalties in its Condensed Consolidated Statement of Income during the three months ended March 31, 2015.  As of March 31, 2016, the Company had accrued $1.5 million for cumulative interest and $1.9 million for cumulative penalties in its Condensed Consolidated Balance Sheets, compared to $1.5 million for cumulative interest and $1.9 million for cumulative penalties accrued at December 31, 2015.

During the three months ended March 31, 2016 and 2015, the Company recognized a decrease of $0.8 million and $0.7 million, respectively, in its cumulative liability for gross unrecognized tax benefits due to the expiration of the applicable statutes of limitations for certain tax years.

The Company estimates that during the year ending December 31, 2016 it will reduce its cumulative liability for gross unrecognized tax benefits by approximately $1.9 million to $2.0 million due to the expiration of the statute of limitations with regard to certain tax positions.  This estimated reduction in the cumulative liability for unrecognized tax benefits does not consider any increase in liability for unrecognized tax benefits with regard to existing tax positions or any increase in cumulative liability for unrecognized tax benefits with regard to new tax positions for the year ending December 31, 2016.

The Company and its subsidiaries are subject to U.S. Federal income tax, as well as the income tax of various state and foreign tax jurisdictions.  Tax years that remain subject to examination by major tax jurisdictions include Brazil from 2000, Italy from 2007, France from 2008, the Netherlands and the United Kingdom from 2010, Spain from 2011, China and the United States from 2012, and various domestic state tax jurisdictions from 1993.

The Italian tax authorities have assessed additional tax due from the Company’s subsidiary, Quaker Italia S.r.l., relating to the tax years 2007, 2008, 2009 and 2010.  In the first quarter of 2016, the Italian tax authorities delivered an audit report to Quaker Italia S.r.l. for the tax years 2011, 2012 and 2013 alleging additional tax due.In the fourth quarter of 2015, the Dutch tax authorities assessed the Company’s subsidiary, Quaker Chemical B.V., for additional income taxes related to the 2011 tax year and Quaker Chemical B.V. filed a protest of such assessment.  In the first quarter of 2016, the French tax authorities gave notice that they were auditing the Company’s subsidiary, Quaker Chemical S.A.  As of March 31, 2016, the Company believes it has adequate reserves, where merited, for uncertain tax positions with respect to all of these audits.     

Note 9 – Earnings Per Share

The following table summarizes earnings per share calculations for the three months ended March 31, 2016 and 2015:

		Three Months Ended
		March 31,
		2016		2015
Basic earnings per common share
	Net income attributable to Quaker Chemical Corporation	$	12,946	$	10,378
	Less: income allocated to participating securities		(113)		(96)
	Net income available to common shareholders	$	12,833	$	10,282
	Basic weighted average common shares outstanding		13,116,807		13,188,761
Basic earnings per common share		$	0.98	$	0.78
Diluted earnings per common share
	Net income attributable to Quaker Chemical Corporation	$	12,946	$	10,378
	Less: income allocated to participating securities		(113)		(96)
	Net income available to common shareholders	$	12,833	$	10,282
	Basic weighted average common shares outstanding		13,116,807		13,188,761
	Effect of dilutive securities		12,587		19,896
	Diluted weighted average common shares outstanding		13,129,394		13,208,657
Diluted earnings per common share		$	0.98	$	0.78

The following aggregate numbers of stock options and restricted stock units are not included in the diluted earnings per share calculation since the effect would have been anti-dilutive: 11,742 and 4,497 for the three months ended March 31, 2016 and 2015, respectively.

13

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements - Continued

(Dollars in thousands, except share and per share amounts, unless otherwise stated)

(Unaudited)

Note 10 – Goodwill and Other Intangible Assets

The Company completes its annual impairment test as of the end of the third quarter of each year, or more frequently if triggering events indicate a possible impairment in one or more of its reporting units.  The Company continually evaluates financial performance, economic conditions and other relevant developments in assessing if an interim period impairment test for one or more of its reporting units is necessary.  The Company has recorded no impairment charges in its past.  Changes in the carrying amount of goodwill for the three months ended March 31, 2016 were as follows:

		North						South
		America		EMEA		Asia/Pacific		America		Total
Balance as of December 31, 2015		$	42,443	$	19,280	$	15,244	$	2,144	$	79,111
	Goodwill additions (reductions)		—		(153)		—		—		(153)
	Currency translation adjustments		9		678		165		193		1,045
Balance as of March 31, 2016		$	42,452	$	19,805	$	15,409	$	2,337	$	80,003

Gross carrying amounts and accumulated amortization for definite-lived intangible assets as of March 31, 2016 and December 31, 2015 were as follows:

	Gross Carrying				Accumulated
	Amount				Amortization
	2016		2015		2016		2015
Customer lists and rights to sell	$	68,180	$	67,435	$	17,030	$	15,806
Trademarks and patents		23,533		23,147		6,087		5,538
Formulations and product technology		5,808		5,808		4,128		4,082
Other		5,869		5,788		4,781		4,565
Total definite-lived intangible assets	$	103,390	$	102,178	$	32,026	$	29,991

The Company recorded $1.8 million and $1.6 million of amortization expense for the three months ended March 31, 2016 and 2015, respectively.  Estimated annual aggregate amortization expense for the current year and subsequent five years is as follows:

For the year ended December 31, 2016	$	6,895
For the year ended December 31, 2017		6,523
For the year ended December 31, 2018		6,303
For the year ended December 31, 2019		6,201
For the year ended December 31, 2020		5,924
For the year ended December 31, 2021		5,557

The Company has two indefinite-lived intangible assets totaling $1.1 million for trademarks at March 31, 2016 and December 31, 2015.

Note 11 – Debt

The Company’s primary credit facility is a $300.0 million syndicated multicurrency credit agreement with a group of lenders, which matures in June 2018.  The maximum amount available under this credit facility can be increased to $400.0 million at the Company’s option if the lenders agree and the Company satisfies certain conditions.  Borrowings under this credit facility generally bear interest at a base rate or LIBOR rate plus a margin.  Access to this credit facility is dependent on meeting certain financial and other covenants, but primarily depends on the Company’s consolidated leverage ratio calculation, which cannot exceed 3.50 to 1.  At March 31, 2016 and December 31, 2015, the Company’s consolidated leverage ratio was below 1.0 to 1, and the Company was also in compliance with all of the other covenants.  At March 31, 2016 and December 31, 2015, the Company had $79.1 million and $62.9 million outstanding, respectively, under its credit facilities.  The Company’s other debt obligations were primarily industrial development bonds and municipality-related loans as of March 31, 2016 and December 31, 2015.    

14

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements - Continued

(Dollars in thousands, except share and per share amounts, unless otherwise stated)

(Unaudited)

Note 12 – Equity

In May 2015, the Company’s Board of Directors authorized a share repurchase program for the repurchase of up to $100.0 million of Quaker Chemical Corporation common stock (the “2015 Share Repurchase Program”).  The 2015 Share Repurchase Program has no expiration date.  The 2015 Share Repurchase Program provides a framework of conditions under which management can repurchase shares of the Company’s common stock.  The Company intends to repurchase shares to at least offset the dilutive impact of shares issued each year as part of its employee benefit and share based compensation plans, and could repurchase more if the Company considers the share price to be at an amount that it considers an advantageous return for its shareholders.  The purchases may be made in the open market or in private and negotiated transactions, in accordance with applicable laws, rules and regulations.  In connection with the 2015 Share Repurchase Program, the remaining unutilized 1995 and 2005 Board of Directors authorized share repurchase programs were terminated.

In connection with the 2015 Share Repurchase Program, the Company acquired 83,879 shares of common stock, for $5.9 million, during the three months ended March 31, 2016, and had no repurchases during the three months ended March 31, 2015.  The Company has elected not to hold treasury shares, and, therefore, has retired the shares as they are repurchased.  It is the Company’s accounting policy to record the excess paid over par value as a reduction in retained earnings for all shares repurchased.

The following tables present the changes in equity, net of tax, for the three months ended March 31, 2016 and 2015:

									Accumulated
					Capital in				Other
			Common		Excess of		Retained		Comprehensive		Noncontrolling
			Stock		Par Value		Earnings		Loss		Interest		Total
Balance at December 31, 2015			$	13,288	$	106,333	$	326,740	$	(73,316)	$	8,198	$	381,243
	Net income			—		—		12,946		—		398		13,344
	Amounts reported in other comprehensive
		income		—		—		—		5,314		62		5,376
	Repurchases of common stock			(84)		—		(5,775)		—		—		(5,859)
	Dividends ($0.32 per share)			—		—		(4,227)		—		—		(4,227)
	Share issuance and equity-based compensation
		plans		32		1,513		—		—		—		1,545
	Excess tax benefit from stock option exercises			—		104		—		—		—		104
Balance at March 31, 2016			$	13,236	$	107,950	$	329,684	$	(68,002)	$	8,658	$	391,526
Balance at December 31, 2014			$	13,301	$	99,056	$	299,524	$	(54,406)	$	7,660	$	365,135
	Net income			—		—		10,378		—		229		10,607
	Amounts reported in other comprehensive
		(loss) income		—		—		—		(8,565)		30		(8,535)
	Dividends ($0.30 per share)			—		—		(4,000)		—		—		(4,000)
	Share issuance and equity-based compensation
		plans		31		1,604		—		—		—		1,635
	Excess tax benefit from stock option exercises			—		287		—		—		—		287
Balance at March 31, 2015			$	13,332	$	100,947	$	305,902	$	(62,971)	$	7,919	$	365,129

15

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements - Continued

(Dollars in thousands, except share and per share amounts, unless otherwise stated)

(Unaudited)

The following tables show the reclassifications from and resulting balances of accumulated other comprehensive loss (“AOCI”) for the three months ended March 31, 2016 and 2015:

							Unrealized
			Currency		Defined		Gain (Loss) in
			Translation		Benefit		Available-for-
			Adjustments		Pension Plans		Sale Securities		Total
Balance at December 31, 2015			$	(38,544)	$	(35,251)	$	479	$	(73,316)
	Other comprehensive income (loss) before
		reclassifications		4,671		(477)		192		4,386
	Amounts reclassified from AOCI			—		798		498		1,296
	Current period other comprehensive income			4,671		321		690		5,682
	Related tax amounts			—		(134)		(234)		(368)
	Net current period other comprehensive income			4,671		187		456		5,314
Balance at March 31, 2016			$	(33,873)	$	(35,064)	$	935	$	(68,002)
Balance at December 31, 2014			$	(14,312)	$	(41,551)	$	1,457	$	(54,406)
	Other comprehensive (loss) income before
		reclassifications		(11,113)		2,498		270		(8,345)
	Amounts reclassified from AOCI			—		881		(164)		717
	Current period other comprehensive (loss) income			(11,113)		3,379		106		(7,628)
	Related tax amounts			—		(901)		(36)		(937)
	Net current period other comprehensive (loss) income			(11,113)		2,478		70		(8,565)
Balance at March 31, 2015			$	(25,425)	$	(39,073)	$	1,527	$	(62,971)

Approximately 70% and 30% of the amounts reclassified from accumulated other comprehensive loss to the Condensed Consolidated Statement of Income for defined benefit retirement plans during the three months ended March 31, 2016 and 2015 were recorded in SG&A and cost of goods sold, respectively.  See Note 6 of Notes to Condensed Consolidated Financial Statements for further information.  All reclassifications related to unrealized gain (loss) in available-for-sale securities relate to the Company’s equity interest in a captive insurance company and are recorded in equity in net income of associated companies.  The amounts reported in other comprehensive income for non-controlling interest are related to currency translation adjustments.

Note 13 – Business Acquisitions

In July 2015, the Company acquired Verkol, S.A. (“Verkol”), a leading specialty grease and other lubricants manufacturer based in northern Spain, included in its EMEA reportable operating segment, for 37.7 million EUR, or approximately $41.4 million.  This includes a post-closing adjustment of 1.3 million EUR, or approximately $1.4 million that was accrued as of December 31, 2015 and paid during the first quarter of 2016.  The purchase included cash acquired of 14.1 million EUR, or approximately $15.4 million, and assumed long-term debt of 2.2 million EUR, or approximately $2.4 million.

16

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements - Continued

(Dollars in thousands, except share and per share amounts, unless otherwise stated)

(Unaudited)

During the first quarter of 2016, the Company identified and recorded an adjustment to the allocation of the purchase price for the Verkol acquisition.  The adjustment was the result of the Company assessing additional information related to assets acquired during the one-year measurement period following the acquisition.  As of March 31, 2016, the allocation of the purchase price for the Verkol acquisition has not been finalized and the one-year measurement period has not ended.  Further adjustments may be necessary as a result of the Company’s on-going assessment of additional information related to the fair value of assets acquired and liabilities assumed.  The following table presents the current allocation of the purchase price of the assets acquired and liabilities assumed:

Verkol Acquisition
Current assets (includes cash acquired)		$	31,151
Property, plant and equipment			7,941
Intangibles
	Customer lists and rights to sell		6,146
	Trademarks and patents		5,378
	Other intangibles		219
Goodwill			5,012
Other long-term assets			158
	Total assets purchased		56,005
Current liabilities			(6,681)
Long-term debt			(2,400)
Other long-term liabilities			(5,531)
	Total liabilities assumed		(14,612)
	Gross cash paid for acquisition	$	41,393
	Less: cash acquired		15,423
	Net cash paid for acquisition	$	25,970

In November 2014, the Company acquired Binol AB, a leading bio-lubricants producer primarily serving the Nordic region, included in its EMEA reportable operating segment, for 136.5 million SEK, or approximately $18.5 million, which is net of 4.4 million SEK, or approximately $0.5 million, received by the Company as part of a post-closing adjustment in the first quarter of 2015.

The results of operations of the acquired businesses and assets are included in the Condensed Consolidated Statements of Income from their respective acquisition dates.  Transaction expenses associated with these acquisitions are included in SG&A in the Company’s Condensed Consolidated Statements of Income.  Certain pro forma and other information are not presented, as the operations of the acquired businesses are not material to the overall operations of the Company for the periods presented.

Note 14 – Fair Value Measurements

The Company has valued its company-owned life insurance policies at fair value.  The Company’s assets subject to fair value measurement were as follows:

			Fair Value Measurements at March 31, 2016
	Total			Using Fair Value Hierarchy
Assets	Fair Value			Level 1		Level 2		Level 3
Company-owned life insurance	$	1,343		$	—	$	1,343	$	—
Total	$	1,343		$	—	$	1,343	$	—

			Fair Value Measurements at December 31, 2015
	Total			Using Fair Value Hierarchy
Assets	Fair Value			Level 1		Level 2		Level 3
Company-owned life insurance	$	1,336		$	—	$	1,336	$	—
Total	$	1,336		$	—	$	1,336	$	—

The fair values of Company-owned life insurance assets are based on quotes for like instruments with similar credit ratings and terms.  The Company did not hold any Level 3 investments as of March 31, 2016 or December 31, 2015, respectively, so related disclosures have not been included.

17

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements - Continued

(Dollars in thousands, except share and per share amounts, unless otherwise stated)

(Unaudited)

Note 15 – Commitments and Contingencies

In 1992, the Company identified certain soil and groundwater contamination at AC Products, Inc. (“ACP”), a wholly owned subsidiary.  In voluntary coordination with the Santa Ana California Regional Water Quality Board (“SACRWQB”), ACP has been remediating the contamination, the principal contaminant of which is perchloroethylene (“PERC”).  In 2004, the Orange County Water District (“OCWD”) filed a civil complaint against ACP and other parties seeking to recover compensatory and other damages related to the investigation and remediation of the contamination in the groundwater.  Pursuant to a settlement agreement with OCWD, ACP agreed, among other things, to operate the two groundwater treatment systems to hydraulically contain groundwater contamination emanating from ACP’s site until the concentrations of PERC released by ACP fell below the current Federal maximum contaminant level for four consecutive quarterly sampling events.  In February 2014, ACP ceased operation at one of its two groundwater treatment systems, as it had met the above condition for closure.  Based on the most recent modeling, it is estimated that the remaining system will operate for another nine months to thirty three months. 

As of March 31, 2016, the Company believes that the range of potential-known liabilities associated with the balance of the ACP water remediation program is approximately $0.2 million to $0.9 million, for which the Company has sufficient reserves.  The low and high ends of the range are based on the length of operation of the treatment system as determined by groundwater modeling.  Costs of operation include the operation and maintenance of the extraction well, groundwater monitoring and program management.

The Company believes, although there can be no assurance regarding the outcome of other unrelated environmental matters, that it has made adequate accruals for costs associated with other environmental problems of which it is aware.  Approximately $0.2 million and $0.3 million was accrued at March 31, 2016 and December 31, 2015, respectively, to provide for such anticipated future environmental assessments and remediation costs.

An inactive subsidiary of the Company that was acquired in 1978 sold certain products containing asbestos, primarily on an installed basis, and is among the defendants in numerous lawsuits alleging injury due to exposure to asbestos.  The subsidiary discontinued operations in 1991 and has no remaining assets other than the proceeds received from insurance settlements.  To date, the overwhelming majority of these claims have been disposed of without payment and there have been no adverse judgments against the subsidiary.  Based on a continued analysis of the existing and anticipated future claims against this subsidiary, it is currently projected that the subsidiary’s total liability over the next 50 years for these claims is less than $3.0 million (excluding costs of defense).  Although the Company has also been named as a defendant in certain of these cases, no claims have been actively pursued against the Company, and the Company has not contributed to the defense or settlement of any of these cases pursued against the subsidiary.  These cases were handled by the subsidiary’s primary and excess insurers who had agreed in 1997 to pay all defense costs and be responsible for all damages assessed against the subsidiary arising out of existing and future asbestos claims up to the aggregate limits of their policies.  A significant portion of this primary insurance coverage was provided by an insurer that is insolvent, and the other primary insurers asserted that the aggregate limits of their policies have been exhausted.  The subsidiary challenged the applicability of these limits to the claims being brought against the subsidiary.  In response, two of the three carriers entered into separate settlement and release agreements with the subsidiary in 2005 and 2007 for $15.0 million and $20.0 million, respectively.  The proceeds of both settlements are restricted and can only be used to pay claims and costs of defense associated with the subsidiary’s asbestos litigation.  In 2007, the subsidiary and the remaining primary insurance carrier entered into a Claim Handling and Funding Agreement, under which the carrier is paying 27% of defense and indemnity costs incurred by or on behalf of the subsidiary in connection with asbestos bodily injury claims.  The agreement continues until terminated and can only be terminated by either party by providing a minimum of two years prior written notice.  As of March 31, 2016, no notice of termination has been given under this agreement.  At the end of the term of the agreement, the subsidiary may choose to again pursue its claim against this insurer regarding the application of the policy limits.  The Company believes that, if the coverage issues under the primary policies with the remaining carrier are resolved adversely to the subsidiary and all settlement proceeds were used, the subsidiary may have limited additional coverage from a state guarantee fund established following the insolvency of one of the subsidiary’s primary insurers.  Nevertheless, liabilities in respect of claims may exceed the assets and coverage available to the subsidiary.

If the subsidiary’s assets and insurance coverage were to be exhausted, claimants of the subsidiary could actively pursue claims against the Company because of the parent-subsidiary relationship.  The Company does not believe that such claims would have merit or that the Company would be held to have liability for any unsatisfied obligations of the subsidiary as a result of such claims.  After evaluating the nature of the claims filed against the subsidiary and the small number of such claims that have resulted in any payment, the potential availability of additional insurance coverage at the subsidiary level, the additional availability of the Company’s own insurance and the Company’s strong defenses to claims that it should be held responsible for the subsidiary’s obligations because of the parent-subsidiary relationship, the Company believes it is not probable that the Company will incur losses.  The Company has been successful to date having claims naming it dismissed during initial proceedings.  Since the Company may be in this early stage of litigation for some time, it is not possible to estimate additional losses or range of loss, if any.

18

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements - Continued

(Dollars in thousands, except share and per share amounts, unless otherwise stated)

(Unaudited)

As initially disclosed in 2010, one of the Company’s subsidiaries may have paid certain value-added-taxes (“VAT”) incorrectly and, in certain cases, may not have collected sufficient VAT from certain customers.  The VAT rules and regulations at issue are complex, vary among the jurisdictions and can be contradictory, in particular as to how they relate to the subsidiary’s products and to sales between jurisdictions.  Since its inception, the subsidiary had been consistent in its VAT collection and remittance practices and had never been contacted by any tax authority relative to VAT.  The subsidiary later determined that for certain products, a portion of the VAT was incorrectly paid and that the total VAT due exceeded the amount originally collected and remitted by the subsidiary.  In response, the subsidiary modified its VAT invoicing and payment procedures to eliminate or mitigate future exposure.

In 2010, three jurisdictions contacted the subsidiary and, since then, the subsidiary has either participated in an amnesty program or entered into a settlement whereby it paid a reduced portion of the amounts owed in resolution of those jurisdictions’ claims.  In 2013, an additional jurisdiction issued an assessment against the subsidiary for certain tax years.  During the fourth quarter of 2015, the subsidiary participated in an amnesty program whereby it paid a reduced portion of the amounts owed in resolution of the jurisdictions’ claims.  As a result, the Company had no remaining accruals for these or any other related tax assessments at March 31, 2016 or December 31, 2015.

In analyzing the subsidiary’s exposure, it is difficult to estimate both the probability and the amount of any potential liabilities due to a number of factors, including: the decrease in exposure over time due to applicable statutes of limitations and actions taken by the subsidiary, the joint liability of customers and suppliers for a portion of the VAT, the availability of a VAT refund for VAT incorrectly paid through an administrative process, any amounts which may have been or will be paid by customers, as well as the timing and structure of any tax amnesties or settlements.  In addition, interest and penalties on any VAT due can be a multiple of the base tax.  The subsidiary may contest any tax assessment administratively and/or judicially for an extended period of time, but may ultimately resolve its disputes through participation in tax amnesty programs, which are a common practice for settling tax disputes in the jurisdictions in question and which have historically occurred on a regular basis, resulting in significant reductions of interest and penalties.  Also, the timing of payments and refunds of VAT may not be contemporaneous, and, if additional VAT is owed, it may not be fully recoverable from customers.  As of March 31, 2016, the Company believes there is one potentially impacted jurisdiction remaining, and if the jurisdiction were to initiate audits and issue assessments, the remaining exposure, net of refunds, could be from $0 million to $1.0 million, assuming the continued availability of future amnesty programs or settlements to reduce the interest and penalties.  If there are future assessments but no such future amnesty programs or settlements, the potential exposure could be higher.

The Company is party to other litigation which management currently believes will not have a material adverse effect on the Company’s results of operations, cash flows or financial condition.

19

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations. 

Executive Summary

Quaker Chemical Corporation is a leading global provider of process fluids, chemical specialties, and technical expertise to a wide range of industries, including steel, aluminum, automotive, mining, aerospace, tube and pipe, cans, and others.  For nearly 100 years, Quaker has helped customers around the world achieve production efficiency, improve product quality, and lower costs through a combination of innovative technology, process knowledge, and customized services.  Headquartered in Conshohocken , Pennsylvania USA, Quaker serves businesses worldwide with a network of dedicated and experienced professionals whose mission is to make a difference.

The Company delivered solid operating results in the first quarter of 2016 despite various challenges that continue in its global end-markets.  Net sales were $178.1 million in the first quarter of 2016 compared to $181.3 million in the first quarter of 2015.  Acquisition and base volume-related net sales growth of 5% quarter-over-quarter was more than offset by the negative impact of foreign currency translation of $8.0 million, or approximately 5%, and declines in selling price and product mix of 2%.  Gross profit increased 2%, primarily from an expansion of gross margin to 38.1% in the first quarter of 2016 compared to 36.6% in the first quarter of 2015, as the Company’s gross margin continued to benefit from the timing of certain raw material cost decreases.  Selling, general and administrative expenses (“SG&A”) increased $0.2 million in the first quarter of 2016 compared to the first quarter of 2015, primarily due to incremental costs associated with the Company’s 2015 Verkol S.A. (“Verkol”) acquisition and higher overall labor-related costs, largely offset by decreases from foreign currency translation.  Operating income increased approximately 8% in the first quarter of 2016 to $19.2 million, compared to $17.9 million in the first quarter of 2015, primarily due to the expansion of gross margin noted above, as well as the relatively consistent level of SG&A quarter-over-quarter.  This drove the Company’s adjusted EBITDA to increase 8% to $25.0 million in the first quarter of 2016 compared to $23.2 million in the first quarter of 2015.  The Company’s solid operating performance in the first quarter of 2016, as well as the impact of other non-operating items, partially offset by a higher tax rate, resulted in earnings per diluted share of $0.98 in the first quarter of 2016 compared to $0.78 in the first quarter of 2015, with non-GAAP earnings per diluted share increasing 4% to $0.98 in the first quarter of 2016 compared to $0.94 in the first quarter of 2015.  Notably, the first quarter of 2015 reported results included a larger non-GAAP currency conversion charge of $2.8 million, or $0.21 per diluted share, related to changes in Venezuela’s foreign exchange markets and currency controls.  The Company was able to achieve these reported and non-GAAP results in the first quarter of 2016 despite negative impacts from foreign exchange of $0.02 per diluted share, or 2%, and continued weakness in global steel production.  See the Non-GAAP Measures section of this Item, below, as well as other items discussed in the Company’s Consolidated Operations Review, in the Operations section of this Item, below.

The Company’s global restructuring program was initiated in the fourth quarter of 2015, and, given its early stages, the Company did not realize material cost savings during the first quarter of 2016.  However, the Company continues to execute the program as initially planned and projects pre-tax cost savings as a result of this program to be approximately $3 million in 2016 and approximately $6 million annually in subsequent years. 

From a regional perspective, the Company’s first quarter of 2016 operating performance was primarily driven by growth in its three largest regions, North America, Europe, Middle East and Africa (“EMEA”) and Asia/Pacific.  All three regions had quarter-over-quarter operating earnings growth driven by increased product volumes and higher gross margins, which more than offset the negative impacts of foreign currency translation and selling price pressure.  Related to EMEA, the region’s results also benefited from the Company’s third quarter of 2015 acquisition of Verkol.  Partially offsetting the performance in its three major regions, the Company’s smallest region, South America, continued to be negatively affected by weak economic conditions, lower volumes due to decreased end-user production, as well as negative impacts from foreign currency translation.  These negative impacts on South America’s performance were partially offset by the positive effects of selling price and product mix and lower labor-related costs as a result of the cost streamlining initiatives taken in this segment in prior years.  See the Reportable Operating Segment Review, in the Operations section of this Item, below. 

The Company’s solid operating performance, coupled with lower cash invested in the Company’s working capital, increased net operating cash flows by approximately 34% to $10.9 million in the first quarter of 2016 compared to $8.1 million in the first quarter of 2015.  The notable drivers of the Company’s working capital improvement are further discussed in the Company’s Liquidity and Capital Resources section of this Item, below. 

Overall, the Company is pleased with its solid results in the first quarter of 2016.  The Company was able to grow volumes both organically by 1% and from acquisitions by 4%, as each of the Company’s major regions had volume growth and increased earnings, despite continued market challenges.  In addition, while the Company’s sales continued to be impacted by downward price adjustments due to declining raw material costs, the timing of these changes allowed the Company to further expand its gross margin.  This performance, coupled with controlled SG&A levels, drove significant operating income growth quarter-over-quarter, which led to strong increases in adjusted EBITDA and cash flow from the first quarter of 2015.  Notably, these results were achieved despite the negative impact from foreign exchange on net sales and earnings of 5% and 2%, respectively, and an approximately 3.5% decline in global steel production compared to the first quarter of 2015. 

20

Looking forward to the remainder of 2016, the Company anticipates some decline in gross margin due to timing differences between raw material price changes and our product pricing adjustments, however, the Company expects benefits from its global restructuring program and its track record of market share gains and leveraging of past acquisitions will continue to help offset these market challenges.  In addition, the Company’s strong cash flow generation and balance sheet continue to be strengths that will support future key strategic initiatives and acquisitions.  Overall, the Company remains confident in its future and expects 2016 will continue to be another good year for Quaker, as the Company continues to forecast growth in both its top and bottom lines during 2016, and still expects to increase non-GAAP earnings and adjusted EBITDA for the seventh consecutive year.

Liquidity and Capital Resources

Quaker’s cash and cash equivalents increased to $94.4 million at March 31, 2016 from $81.1 million at December 31, 2015.  The $13.3 million increase was the net result of $10.9 million of cash provided by operating activities, $4.3 million of cash provided by financing activities and a $1.4 million increase due to the effect of changes in exchange rates on cash, partially offset by $3.3 million of cash used in investing activities.

Net cash flows provided by operating activities were $10.9 million in the first quarter of 2016 compared to $8.1 million in the first quarter of 2015.  The $2.8 million increase in cash flows provided by operating activities was driven primarily by solid operating performance coupled with lower cash invested in the Company’s working capital during the first quarter of 2016 compared to the first quarter of 2015.  Partially offsetting these increases was a quarter-over-quarter increase in cash outflows related to pension and postretirement benefits due to timing and the level of pension contributions.  The decrease in cash invested in the Company’s working capital and other current assets and liabilities was primarily due to the timing of payments for certain prepaid expenses and other current assets, including prepaid taxes.  In addition, the net cash outflow from changes in accounts receivable, inventories, and accounts payable and accrued liabilities was slightly improved in the first quarter of 2016 compared to the first quarter of 2015, primarily due to improved working capital management.  Partially offsetting these increases in cash flow were restructuring payments made in the first quarter of 2016, as part of the Company’s global restructuring program initiated in the fourth quarter of 2015. 

Net cash flows used in investing activities increased from $1.7 million in the first quarter of 2015 to $3.3 million in the first quarter of 2016, primarily due to higher payments for acquisitions.  The Company had a cash outflow of $1.4 million during the first quarter of 2016 due to a post-closing adjustment to finalize its 2015 acquisition of Verkol, compared to a cash inflow of $0.5 million during the first quarter of 2015 due to a post-closing adjustment to finalize its 2014 acquisition of Binol AB.  This higher cash outflow was partially offset by changes in the Company’s restricted cash, which is dependent upon the timing of claims and payments associated with a subsidiary’s asbestos litigation, as well as lower spending related to property, plant and equipment compared to the first quarter of 2015. 

Net cash flows provided by financing activities were $4.3 million in the first quarter of 2016 compared to cash used in financing activities of $5.1 million in the first quarter of 2015.  The $9.4 million increase in cash flows was primarily due to proceeds from long-term debt, net of repayments, of $14.5 million in the first quarter of 2016 compared to long-term debt repayments of $1.3 million in the first quarter of 2015.  These borrowings funded increased net cash flows used in the Company’s investing activities, described above, increased dividend payments in the first quarter of 2016 compared to the first quarter of 2015, and, also, cash outflows of $5.9 million in the first quarter of 2016 to repurchase 83,879 shares of the Company’s common stock pursuant to the Company’s share repurchase program.

The Company’s primary credit facility is a $300.0 million syndicated multicurrency credit agreement with a group of lenders, which matures in June 2018.  The maximum amount available under this credit facility can be increased to $400.0 million at the Company’s option if the lenders agree and the Company satisfies certain conditions.  Borrowings under this credit facility generally bear interest at a base rate or LIBOR rate plus a margin.  Access to this credit facility is dependent on meeting certain financial and other covenants, but primarily depends on the Company’s consolidated leverage ratio calculation, which cannot exceed 3.50 to 1.  As of March 31, 2016 and December 31, 2015, the Company’s consolidated leverage ratio was below 1.0 to 1, and the Company was also in compliance with all of the other covenants.  At March 31, 2016 and December 31, 2015, the Company had $79.1 million and $62.9 million outstanding, respectively, under its credit facilities.  The Company’s other debt obligations were primarily industrial development bonds and municipality-related loans as of March 31, 2016 and December 31, 2015. 

Related to the Company’s global restructuring program initiated in the fourth quarter of 2015, the Company did not incur additional restructuring expenses during the first quarter of 2016 and continues to execute the program as initially planned.  Given its early stages, the Company has not realized material cost savings to date, but continues to project pre-tax cost savings as a result of this program to be approximately $3 million in 2016 and approximately $6 million annually in subsequent years.  In addition, the Company still expects to substantially complete this program during 2016, utilizing operating cash flows for the settlement of its remaining restructuring liabilities.

21

At March 31, 2016, the Company’s gross liability for uncertain tax positions, including interest and penalties, was $14.8 million. The Company cannot determine a reliable estimate of the timing of cash flows by period related to its uncertain tax position liability. However, should the entire liability be paid, the amount of the payment may be reduced by up to $9.3 million as a result of offsetting benefits in other tax jurisdictions.

The Company believes it is capable of supporting its operating requirements and funding its business objectives, including but not limited to, pension plan contributions, payments of dividends to shareholders, potential share repurchases, possible acquisitions and other business opportunities, capital expenditures and possible resolution of contingencies, through internally generated funds supplemented with debt or equity as needed.

Non-GAAP Measures

Included in this Form 10-Q filing are two non-GAAP (unaudited) financial measures: non-GAAP earnings per diluted share and adjusted EBITDA.  The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader’s understanding of the financial performance of the Company, are more indicative of future operating performance of the Company, and facilitate a better comparison among fiscal periods, as the non-GAAP measures exclude items that are not considered core to the Company’s operations.  Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP.  The following tables reconcile non-GAAP earnings per diluted share (unaudited) and adjusted EBITDA (unaudited) to their most directly comparable GAAP (unaudited) financial measures:

	Three Months Ended
	March 31,
		2016		2015
GAAP earnings per diluted share attributable to Quaker Chemical Corporation common shareholders	$	0.98	$	0.78
Equity income in a captive insurance company per diluted share		(0.01)		(0.06)
Cost streamlining initiative per diluted share		—		0.01
Currency conversion impact of the Venezuelan bolivar fuerte per diluted share		0.01		0.21
Non-GAAP earnings per diluted share	$	0.98	$	0.94

	Three Months Ended
	March 31,
		2016		2015
Net income attributable to Quaker Chemical Corporation	$	12,946	$	10,378
Depreciation and amortization		4,934		4,698
Interest expense		741		587
Taxes on income before equity in net income of associated companies		6,305		5,359
Equity income in a captive insurance company		(52)		(795)
Cost streamlining initiative		—		173
Currency conversion impact of the Venezuelan bolivar fuerte		88		2,806
Adjusted EBITDA	$	24,962	$	23,206

Operations

Consolidated Operations Review – Comparison of the First Quarter of 2016 with the First Quarter of 2015

Net sales in the first quarter of 2016 of $178.1 million decreased 2% from net sales of $181.3 million in the first quarter of 2015.  The decrease in net sales was primarily due to the negative impact of foreign currency translation of $8.0 million, or approximately 5%, and declines in selling price and product mix of 2%, which collectively offset a 5% increase in product volume, including approximately $7.3 million of sales attributable to the Company’s 2015 acquisition of Verkol. 

Costs of goods sold in the first quarter of 2016 of $110.2 million decreased 4% from $115.0 million in the first quarter of 2015.  This decrease was primarily due to a decline in raw material costs, the mix of products sold, and the impact of foreign currency translation, which were partially offset by increases in product volume, including additional cost of goods sold attributed to the Company’s 2015 acquisition of Verkol.

Gross profit in the first quarter of 2016 increased $1.5 million, or 2%, from the first quarter of 2015, primarily driven by increased product volume, noted above, and higher gross margin of 38.1% in the first quarter of 2016 compared to 36.6% in the first quarter of 2015, partially offset by the negative impact of foreign currency translation.  The expansion in gross margin in the first quarter of 2016 is due to continued timing of certain raw material cost decreases. 

22

SG&A in the first quarter of 2016 increased $0.2 million compared to the first quarter of 2015, which was primarily due to incremental costs associated with the Company’s 2015 acquisition of Verkol and higher overall labor-related costs.  These increases were partially offset by decreases in foreign currency translation and certain one-time charges incurred during the first quarter of 2015, which included $0.2 million, or $0.01 per diluted share, related to a cost streamlining initiative in South America and a $0.2 million, or $0.01 per diluted share charge, related to events at the Company’s Venezuela affiliate. 

Operating income in the first quarter of 2016 was $19.2 million, which increased approximately 8% compared to $17.9 million in the first quarter of 2015.  The increase in operating income was primarily due to the expansion of gross margin in the first quarter of 2016 noted above, as well as the relatively consistent level of SG&A quarter-over-quarter.

The Company had other income of $0.7 million in the first quarter of 2016 compared to other expense of $0.2 million in the first quarter of 2015.  The increase of $0.9 million was primarily driven by foreign exchange transaction gains realized in the first quarter of 2016 compared to foreign exchange transaction losses in the first quarter of 2015.

Interest expense was $0.2 million higher in the first quarter of 2016 compared to the first quarter of 2015, primarily due to higher average borrowings outstanding in the first quarter of 2016 to fund the Company’s recent acquisition activity.  Interest income was relatively flat in the first quarter of 2016 compared to the first quarter of 2015.

The Company’s effective tax rates for the first quarters of 2016 and 2015 were 32.3% and 30.8%, respectively.  The increase in the first quarter of 2016 effective tax rate was primarily due to the Company recording earnings in one of its subsidiaries at a statutory tax rate of 25% while it awaits recertification of a concessionary 15% tax rate, which was available to the Company during the first quarter of 2015.  In addition, the Company has experienced and expects to further experience volatility in its effective tax rates due to the varying timing of tax audits and the expiration of applicable statutes of limitations as they relate to uncertain tax positions, among other factors.  Given all these factors, the Company currently estimates its second quarter of 2016 effective tax rate will continue to be between 31% and 33%.  However, the Company still estimates its full year 2016 effective tax rate will approximate 28% to 30%.

Equity in net income of associated companies (“equity income”) increased by $1.5 million in the first quarter of 2016 compared to the first quarter of 2015.  The increase in equity income was primarily due to a smaller currency conversion charge recorded at the Company’s Venezuela affiliate during the first quarter of 2016, of $0.1 million, or $0.01 per diluted share, compared to the first quarter of 2015 charge of $2.6 million, or $0.20 per diluted share.  See Note 1 of Notes to Condensed Consolidated Financial Statements.  Excluding these charges, the primary component of equity income is earnings from the Company’s interest in a captive insurance company.  Earnings attributable to this equity interest were $0.1 million, or $0.01 per diluted share, in the first quarter of 2016 compared to $0.8 million, or $0.06 per diluted share, in the first quarter of 2015.

The Company had a $0.2 million increase in net income attributable to noncontrolling interest in the first quarter of 2016 compared to the first quarter of 2015, primarily due to stronger performance at its India affiliate.

Changes in foreign exchange rates, excluding the currency conversion impacts of the Venezuelan bolivar fuerte noted above, negatively impacted the Company’s first quarter of 2016 net income by approximately 2%, or $0.02 per diluted share.

Reportable Operating Segment Review

The Company sells its industrial process fluids, chemical specialties and technical expertise to a wide range of industries in a global product portfolio throughout its four segments:  (i) North America, (ii) EMEA, (iii) Asia/Pacific and (iv) South America.

Comparison of the First Quarter of 2016 with the First Quarter of 2015

North America

North America represented approximately 46% of the Company’s consolidated net sales in the first quarter of 2016, and the region’s sales decreased $0.6 million, or 1%, compared to the first quarter of 2015.  The decrease in net sales was primarily due to the negative impact of foreign currency translation of 2% and a decrease in selling price and product mix of 2%, partially offset by higher product volumes of 3%.  The foreign exchange impact was primarily due to a weakening of the Mexican peso against the U.S. dollar, as this exchange rate averaged 18.03 in the first quarter of 2016 compared to 14.95 in the first quarter of 2015.  This reportable segment’s operating earnings, excluding indirect expenses, increased $0.8 million, or 5%, compared to the first quarter of 2015.  The first quarter of 2016 increase was mainly driven by higher gross profit on the increased product volume, noted above, and margin expansion due to continued timing of certain raw material cost decreases.  These increases to operating earnings were partially offset by higher labor-related costs on improved segment performance.

EMEA

EMEA represented approximately 27% of the Company’s consolidated net sales in the first quarter of 2016, and the region’s sales increased $4.5 million, or 10%, compared to the first quarter of 2015.  The increase in net sales was primarily due to higher product volumes, including acquisitions, of 18%, partially offset by decreases in selling price and product mix of approximately 6%, and foreign currency translation of 2%. The foreign exchange impact was primarily due to a weakening of the euro against the U.S. dollar,

23

as this exchange rate averaged 1.10 in the first quarter of 2016 compared to an average of 1.13 in the first quarter of 2015.  This reportable segment’s operating earnings, excluding indirect expenses, increased $1.5 million, or 23%, compared to the first quarter of 2015.  The first quarter of 2016 increase was mainly driven by higher gross profit on the increased net sales, noted above, and margin expansion due to continued timing of certain raw material cost decreases.  These increases to operating earnings were partially offset by incremental operating costs from the 2015 Verkol acquisition and higher labor-related costs on improved segment performance.

Asia/Pacific

Asia/Pacific represented approximately 23% of the Company’s consolidated net sales in the first quarter of 2016, and the region’s sales decreased $3.5 million, or 8%, compared to the first quarter of 2015.  The decrease in net sales was primarily due to the negative impact of foreign currency translation of 6% and a decrease in selling price and product mix of 2%, which offset slightly positive base volume growth.  The foreign exchange impact was primarily due to the weakening of the Chinese renminbi, Indian rupee and Australian dollar against the U.S. dollar, as these exchange rates averaged 6.54, 67.51 and 0.72 in the first quarter of 2016 compared to 6.14, 62.24 and 0.79 in the first quarter of 2015, respectively.  This reportable segment’s operating earnings, excluding indirect expenses, increased $0.6 million, or 6%, compared to the first quarter of 2015.  The first quarter of 2016 increase was mainly driven by higher gross profit on margin expansion due to continued timing of certain raw material cost decreases.  This increase to operating earnings was partially offset by higher labor-related costs on improved segment performance.

South America

South America represented approximately 4% of the Company’s consolidated net sales in the first quarter of 2016, and the region’s sales decreased $3.6 million, or 35%, compared to the first quarter of 2015.  The decrease in net sales was primarily due to the negative impact of foreign currency translation of approximately 27% and lower product volumes of 17%, partially offset by an increase in selling price and product mix of 9%.  The foreign exchange impact was primarily due to the weakening of the Brazilian real and Argentinian peso against the U.S. dollar, as these exchange rates averaged 3.90 and 14.41 in the first quarter of 2016 compared to 2.86 and 8.68 in the first quarter of 2015, respectively.  This reportable segment’s operating earnings, excluding indirect expenses, decreased $1.6 million, or 125%, compared to the first quarter of 2015.  The first quarter of 2016 decrease was mainly driven by lower gross profit on the decreased net sales, noted above, and lower gross margin due primarily to raw material cost increases, partially offset by lower labor-related costs.  This decrease in labor-related costs was primarily due to the segment’s lower performance and the positive effects from the cost streamlining initiatives taken in this segment during prior years.

Factors That May Affect Our Future Results

(Cautionary Statements Under the Private Securities Litigation Reform Act of 1995)

Certain information included in this Report and other materials filed or to be filed by Quaker with the SEC (as well as information included in oral statements or other written statements made or to be made by us) contain or may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  These statements can be identified by the fact that they do not relate strictly to historical or current facts.  We have based these forward-looking statements on our current expectations about future events.  These forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, intentions, financial condition, results of operations, future performance and business, including:

·statements relating to our business strategy;

·our current and future results and plans; and

·statements that include the words “may,” “could,” “should,” “would,” “believe,” “expect,” “anticipate,” “estimate,” “intend,” “plan” or similar expressions.

Such statements include information relating to current and future business activities, operational matters, capital spending, and financing sources.  From time to time, forward-looking statements are also included in Quaker’s other periodic reports on Forms 10-K, 10-Q and 8-K, press releases, and other materials released to, or statements made to, the public.

Any or all of the forward-looking statements in this Report and in any other public statements we make may turn out to be wrong.  This can occur as a result of inaccurate assumptions or as a consequence of known or unknown risks and uncertainties.  Many factors discussed in this Report will be important in determining our future performance.  Consequently, actual results may differ materially from those that might be anticipated from our forward-looking statements.

We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.  However, any further disclosures made on related subjects in Quaker’s subsequent reports on Forms 10-K, 10-Q, 8-K and other related filings should be consulted.  Our forward-looking statements are subject to risks, uncertainties and assumptions about us and our operations that are subject to change based on various important factors, some of which are beyond our control.  A major risk is that demand for the Company’s products and services is largely derived from the demand for its customers’ products,

24

which subjects the Company to uncertainties related to downturns in a customer’s business and unanticipated customer production shutdowns.  Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, customer financial stability, worldwide economic and political conditions, foreign currency fluctuations, future terrorist attacks and other acts of violence.  Furthermore, the Company is subject to the same business cycles as those experienced by steel, automobile, aircraft, appliance, and durable goods manufacturers.  These risks, uncertainties, and possible inaccurate assumptions relevant to our business could cause our actual results to differ materially from expected and historical results. Other factors beyond those discussed could also adversely affect us.  Therefore, we caution you not to place undue reliance on our forward-looking statements.  This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.

25

Item 3.  Quantitative and Qualitative Disclosures About Market Risk.

We have evaluated the information required under this Item that was disclosed in Part II, Item 7A, of our Annual Report on Form 10-K for the year ended December 31, 2015, and we believe there has been no material change to that information.

26

Item 4.  Controls and Procedures.

Evaluation of disclosure controls and procedures.  As required by Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), our management, including our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report.  Based on that evaluation, our principal executive officer and our principal financial officer have concluded that as of the end of the period covered by this report our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) were effective.

Changes in internal control over financial reporting.  As required by Rule 13a-15(d) under the Exchange Act, our management, including our principal executive officer and principal financial officer, has evaluated our internal control over financial reporting to determine whether any changes to our internal control over financial reporting occurred during the quarter ended March 31, 2016 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.  Based on that evaluation, no such changes to our internal control over financial reporting occurred during the quarter ended March 31, 2016.

27

PART II. 

OTHER INFORMATION

Items 1A, 3, 4 and 5 of Part II are inapplicable and have been omitted.

Item 1.  Legal Proceedings

Incorporated by reference is the information in Note 15 of the Notes to the Condensed Consolidated Financial Statements in Part I, Item 1, of this Report.

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds.

The following table sets forth information concerning shares of the Company’s common stock acquired by the Company during the period covered by this report:

				(c)		(d)
				Total Number of		Approximate Dollar
	(a)		(b)	Shares Purchased		Value of Shares that
	Total Number		Average	as part of		May Yet be
	of Shares		Price Paid	Publicly Announced		Purchased Under the
Period	Purchased (1)		Per Share	Plans or Programs		Plans or Programs (1)
January 1 - January 31	83,779	$	69.85	83,779	$	86,872,029
February 1 - February 29	100	$	70.03	100	$	86,865,026
March 1 - March 31	4,654 (2)	$	81.75 (3)	—	$	86,865,026
Total	88,533	$	70.47	83,879	$	86,865,026

(1)On May 6, 2015, the Board of Directors of the Company approved, and the Company announced, a new share repurchase program, pursuant to which the Company is authorized to repurchase up to $100,000,000 of Quaker Chemical Corporation common stock (the “2015 Share Repurchase Program”).  The 2015 Share Repurchase Program has no expiration date.  Except as otherwise indicated in note (2) below, all of the shares acquired by the Company during the periods covered by this report were acquired pursuant to the 2015 Share Repurchase Program.

(2)All of these shares were acquired from employees upon their surrender of previously owned Quaker shares in payment of the exercise price of employee stock options exercised, for the payment of taxes upon exercise of employee stock options or for the vesting of restricted stock.

(3)The price paid for shares acquired from employees pursuant to employee benefit and share-based compensation plans, is, in each case, based on the closing price of the Company’s common stock on the date of exercise or vesting, as specified by the plan pursuant to which the applicable option or restricted stock was granted. 

28

Item 6.  Exhibits

(a) Exhibits
31.1	–	Certification of Chief Executive Officer of the Company pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934
31.2	–	Certification of Chief Financial Officer of the Company pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934
32.1	–	Certification of Chief Executive Officer of the Company Pursuant to 18 U.S. C. Section 1350
32.2	–	Certification of Chief Financial Officer of the Company Pursuant to 18 U.S. C. Section 1350
101.INS	–	XBRL Instance Document
101.SCH	–	XBRL Extension Schema Document
101.CAL	–	XBRL Calculation Linkbase Document
101.DEF	–	XBRL Definition Linkbase Document
101.LAB	–	XBRL Label Linkbase Document
101.PRE	–	XBRL Presentation Linkbase Document

*********

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	QUAKER CHEMICAL CORPORATION                         (Registrant)
	/s/ Mary Dean Hall
Date: April 27, 2016	Mary Dean Hall, Vice President, Chief Financial Officer and Treasurer (officer duly authorized on behalf of, and principal financial officer of, the Registrant)

29

EX-31.1

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER OF THE COMPANY PURSUANT TO RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

I, Michael F. Barry, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Quaker Chemical Corporation;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 27, 2016

/s/ Michael F. Barry

Michael F. Barry

Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER OF THE COMPANY PURSUANT TO RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

I, Mary Dean Hall, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Quaker Chemical Corporation;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 27, 2016

/s/ Mary Dean Hall

Mary Dean Hall

Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

The undersigned hereby certifies that the Form 10-Q Quarterly Report of Quaker Chemical Corporation (the “Company”) for the quarterly period ended March 31, 2016 filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: April 27, 2016	/s/ Michael F. Barry
	Michael F. Barry
	Chief Executive Officer of Quaker Chemical Corporation

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

The undersigned hereby certifies that the Form 10-Q Quarterly Report of Quaker Chemical Corporation (the “Company”) for the quarterly period ended March 31, 2016 filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: April 27, 2016	/s/ Mary Dean Hall
	Mary Dean Hall
	Chief Financial Officer of Quaker Chemical Corporation

XML

Document and Entity Information	3 Months Ended
	Mar. 31, 2016 shares
Document And Entity Information [Abstract]
Document Type	10-Q
Document period end date	Mar. 31, 2016
Amendment flag	false
Document Fiscal Year Focus	2016
Document Period Focus	Q1
Current fiscal year end date	--12-31
Entity central index key	0000081362
Entity current reporting status	Yes
Entity filer category	Large Accelerated Filer
Entity registrant name	Quaker Chemical Corporation
Entity voluntary filers	No
Entity well known seasoned issuer	Yes
Entity common stock shares outstanding	13,236,040
Trading Symbol	KWR

XML

Condensed Consolidated Statement of Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Income Statement [Abstract]
Net Sales	$ 178,077	$ 181,330
Cost of goods sold	110,202	115,002
Gross profit	67,875	66,328
Selling, general and administrative expenses	48,641	48,464
Operating income	19,234	17,864
Other income (expense), net	706	(194)
Interest Expense	(741)	(587)
Interest Income	348	320
Income Before Taxes and Equity in Net Income of Associated Companies	19,547	17,403
Taxes on income before equity in net income of associated companies	6,305	5,359
Income before equity in net income of associated companies	13,242	12,044
Equity in net income (loss) of associated companies	102	(1,437)
Net Income	13,344	10,607
Less: Net income attributable to noncontrolling interest	398	229
Net Income Attributable to Quaker Chemical Corporation	$ 12,946	$ 10,378
Per share data:
Basic Earnings Per Common Share	$ 0.98	$ 0.78
Diluted Earnings per Common Share	0.98	0.78
Dividends Declared	$ 0.32	$ 0.3

XML

Condensed Consolidated Statement of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Statement of Comprehensive Income [Abstract]
Net Income	$ 13,344	$ 10,607
Currency Translation Adjustments	4,733	(11,083)
Defined Benefit Retirement Plans	187	2,478
Unrealized Gain on Available-for-Sale Securities	456	70
Other Comprehensive Income (Loss)	5,376	(8,535)
Comprehensive Income	18,720	2,072
Less: Comprehensive Income Attributable to Noncontrolling Interest	(460)	(259)
Comprehensive Income Attributable to Quaker Chemical Corporation	$ 18,260	$ 1,813

XML

Condensed Consolidated Balance Sheet - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Current assets
Cash and cash equivalents	$ 94,374	$ 81,053
Accounts receivable, net	188,218	188,297
Inventories
Raw materials and supplies	37,322	36,876
Work-in-process and finished goods	40,898	38,223
Prepaid expenses and other current assets	20,537	21,404
Total current assets	381,349	365,853
Property, plant and equipment, at cost	236,811	231,164
Less accumulated depreciation	(149,576)	(143,545)
Net property, plant and equipment	87,235	87,619
Goodwill	80,003	79,111
Other intangible assets, net	72,464	73,287
Investments in associated companies	21,194	20,354
Non-current deferred tax assets	19,916	23,468
Other assets	32,405	32,218
Total assets	694,566	681,910
Current liabilities
Short-term borrowings and current portion of long-term debt	645	662
Accounts and other payables	69,748	71,543
Accrued compensation	13,626	19,166
Accrued restructuring	5,969	6,303
Other current liabilities	25,397	26,881
Total current liabilities	115,385	124,555
Long-term debt	97,620	81,439
Non-current deferred tax liabilities	11,071	11,400
Other non-current liabilities	78,964	83,273
Total liabilities	303,040	300,667
Equity
Common stock $1 par value; authorized 30,000,000 shares; issued and outstanding 2016 - 13,236,040 shares; 2015 - 13,288,113 shares	13,236	13,288
Capital in excess of par value	107,950	106,333
Retained earnings	329,684	326,740
Accumulated Other Comprehensive Loss	(68,002)	(73,316)
Total Quaker shareholders' equity	382,868	373,045
Noncontrolling interest	8,658	8,198
Total equity	391,526	381,243
Total liabilities and equity	$ 694,566	$ 681,910

XML

Condensed Consolidated Balance Sheet (Parentheticals) - $ / shares	Mar. 31, 2016	Dec. 31, 2015
Statement Of Financial Position [Abstract]
Common Stock Par Value	$ 1	$ 1
Common Stock, Shares Authorized	30,000,000	30,000,000
Common Stock, Shares, Issued	13,236,040	13,288,113

XML

Condensed Consolidated Statement of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cash flows from operating activities
Net Income	$ 13,344	$ 10,607
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	3,157	3,071
Amortization	1,777	1,627
Equity in undistributed earnings of associated companies, net of dividends	(27)	1,437
Deferred compensation and other, net	980	1,091
Stock-based compensation	1,798	1,685
Gain on disposal of property, plant and equipment and other assets	(20)	(21)
Insurance settlement realized	(279)	(115)
Pension and other postretirement benefits	(2,685)	10
Increase (decrease) in cash from changes in current assets and current liabilities, net of acquisitions:
Accounts receivable	2,602	3,428
Inventories	(1,800)	(2,584)
Prepaid expenses and other current assets	1,183	(2,634)
Accounts payable and accrued liabilities	(8,647)	(9,516)
Change in restructuring liabilities	(509)	0
Net cash provided by operating activities	10,874	8,086
Cash flows from investing activities
Investments in property, plant and equipment	(2,172)	(2,414)
Payments related to acquisitions, net of cash acquired	(1,384)	528
Proceeds from disposition of assets	26	80
Insurance settlement interest earned	8	10
Change in restricted cash, net	271	105
Net cash used in investing activities	(3,251)	(1,691)
Cash flows from financing activities
Proceeds from long-term debt	14,687	0
Repayment of long-term debt	(159)	(1,327)
Dividends paid	(4,243)	(3,990)
Stock options exercised, other	(253)	(50)
Payments for repurchase of common stock	(5,859)	0
Excess tax benefit related to stock option exercises, cash flow	104	287
Net cash provided by (used in) financing activities	4,277	(5,080)
Effect of exchange rate changes on cash	1,421	(1,708)
Net increase (decrease) in cash and cash equivalents	13,321	(393)
Cash and cash equivalents at beginning of period	81,053	64,731
Cash and cash equivalents at end of period	$ 94,374	$ 64,338

XML

Condensed Financial Information

3 Months Ended

Mar. 31, 2016

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]

Note 1 – Condensed Financial Information

The condensed consolidated financial statements included herein are unaudited and have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial reporting and the United States Securities and Exchange Commission (“SEC”) regulations. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the financial statements reflect all adjustments (consisting only of normal recurring adjustments, except certain material adjustments, as discussed below) which are necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods. The results for the three months endedMarch 31, 2016 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2015. During the first quarter of 2016, the Company revised its Condensed Consolidated Balance Sheet for December 31, 2015, reducing non-current deferred tax assets and non-current deferred tax liabilities by $3.6 million each, to correct for offsetting deferred tax balances within related taxing jurisdictions. The Company considers such revision to be immaterial and the revision had no impact on reported equity, net income or net cash provided by operating activities.

Venezuela’s economy has been considered hyper inflationary under U.S. GAAP since 2010, at which time the Company’s Venezuela equity affiliate,Kelko Quaker Chemical, S.A. (“Kelko Venezuela”), changed its functional currency from the bolivar fuerte (“BsF”) to the U.S. dollar. Accordingly, all gains and losses resulting from the remeasurement of Kelko Venezuela’s monetary assets and liabilities to published exchange rates are required to be recorded directly to the Condensed Consolidated Statement of Income. As of December 31, 2014, there were three legally available exchange rates in Venezuela, the CADIVI (or the official rate, 6.3 BsF per U.S. dollar), the SICAD I and the SICAD II. Kelko Venezuela had access to the CADIVI for imported goods, had not been invited to participate in any SICAD I auctions and had limited access to the SICAD II mechanism. Accordingly, the Company measured its equity investment and other related assets with Kelko Venezuela at the CADIVI exchange rate at December 31, 2014. During thethree months ended March 31, 2015, the Venezuela government announced changes to itsforeign exchange controls. There continued to be three exchange mechanisms, however, they consisted of the CADIVI, a combined SICAD I and SICAD II auction mechanism (the “SICAD”) and a newly created, marginal currency system (the “SIMADI”). In light of the first quarter of 2015 changes to Venezuela’s foreign exchange controls and the on-going economic challenges in Venezuela, the Company re-assessed Kelko Venezuela’s access to U.S. dollars, the impact on the operations of Kelko Venezuela, and the impact on the Company’s equity investment and other related assets, which resulted in revaluing its equity investment in Kelko Venezuela and other related assets to the SIMADI exchange rate of approximately193BsF per U.S. dollar as of March 31, 2015. This resulted in a charge of$2.8 million, or $0.21 per diluted share, recorded in the three months ended March 31, 2015. As of December 31, 2015, the Company’s equity investment in Kelko Venezuela was $0.2 million, and continued to be valued at the SIMADI exchange rate, which was approximately 198 BsF per U.S. dollar.

During the three months ended March 31, 2016, the Venezuela government announced further changes to its foreign exchange controls, including eliminating the CADIVI, SICAD and SIMADI exchange rate mechanisms and replacing them with a new dual foreign exchange rate system. The Company understands that the new dual foreign exchange rate system now consists of a protected “DIPRO” exchange rate, with a rate fixed at 10 Bsf per U.S. dollar and, also, a floating supplementary market exchange rate known as the “DICOM.” The DIPRO rate will only be available for payment of certain imports of essential goods in the food and health sectors while the DICOM will govern all other transactions not covered by DIPRO. As of March 31, 2016, the published rate for the DICOM was approximately 273 BsF per U.S. dollar. In light of these changes to the foreign exchange controls during the three months ended March 31, 2016, the Company again re-assessed Kelko Venezuela’s access to U.S. dollars, the impact on the operations of Kelko Venezuela, and the impact on the Company’s equity investment and other related assets. The Company does not believe it currently has access to the DIPRO and, therefore, believes the DICOM is currently the exchange rate system available to Kelko Venezuela, which resulted in a currency conversion charge of $0.1 million, or $0.01 per diluted share, during the three months ended March 31, 2016. As of March 31, 2016, the Company’s equity investment in Kelko Venezuela was $0.2 million, valued at the DICOM exchange rate.

As part of the Company’s chemical management services, certain third-party product sales to customers are managed by the Company. Where the Company acts as the principal, revenue is recognized on a gross reporting basis at the selling price negotiated with customers. Where the Company acts as an agent, such revenue is recorded using net reporting of service revenue, at the amount of the administrative fee earned by the Company for ordering the goods. Third-party products transferred under arrangements resulting in net reporting totaled $11.1 million and $11.9 million for the three months endedMarch 31, 2016 and 2015, respectively.

XML

Recently Issued Accounting Standards

3 Months Ended

Mar. 31, 2016

New Accounting Pronouncements And Changes In Accounting Principles [Abstract]

Description of New Accounting Pronouncements Not yet Adopted [Text Block]

Note 2 – Recently Issued Accounting Standards

The Financial Accounting Standards Board ("FASB") issued an accounting standard update in March 2016 involving several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, use of a forfeiture rate, and classification on the statement of cash flows. The guidance within this accounting standard update is effective for annual and interim periods beginning after December 15, 2016. Early adoption is permitted, however, if early adoption is elected, all amendments in the update must be adopted in the same period. When adopted, application of the guidance will vary based on each aspect of the update; including on a retrospective, modified retrospective or prospective basis. The Company has not early adopted and is currently evaluating the potential impact of this guidance and considering the appropriate implementation strategy.

The FASB issued an accounting standard update in February 2016 regarding the accounting and disclosure for leases. Specifically, the update will require entities that lease assets to recognize the assets and liabilities for the rights and obligations created by those leases on the balance sheet, in most instances. The guidance within this accounting standard update is effective for annual and interim periods beginning after December 15, 2018, and should be applied on a modified retrospective basis for the reporting periods presented. Early adoption is permitted. The Company has not early adopted and is currently evaluating the potential impact of this guidance and considering the appropriate implementation strategy.

The FASB issued an accounting standard update in November 2015 regarding the classification of deferred taxes on the balance sheet.  The update requires that all deferred tax assets and liabilities, along with any related valuation allowance, be classified as noncurrent on the balance sheet.  The update does not change the existing requirement that only permits offsetting within a jurisdiction.  The guidance within this accounting standard update is effective for annual and interim periods beginning after December 15, 2016, and may be applied either prospectively, for all deferred tax assets and liabilities, or retrospectively.  Early adoption is permitted.  The Company has not early adopted. Adoption of the guidance will not have an impact on the Company’s earnings or cash flow but will result in a balance sheet reclassification between current and long-term assets and liabilities.

The FASB issued an accounting standard update in July 2015 regarding simplifying the measurement of inventory.  The guidance is applicable for entities that measure inventory using the FIFO or average cost methods.  Specifically, the update requires that inventory be measured at lower of cost or net realizable value.  Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.  The amendments in this update are effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years.  This guidance should be applied prospectively with early adoption permitted. As of March 31, 2016, the Company has elected to early adopt this guidance without a material impact.

The FASB issued an accounting standard update in May 2015 regarding the required disclosures for entities that elect to measure the fair value of certain investments using the net asset value per share (or its equivalent) practical expedient in accordance with the fair value measurement authoritative guidance.  The update removes the requirement to categorize within the fair value hierarchy, and also limits the requirement to make certain other disclosures, for all such investments.  The amendments in this update are effective for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years, and should be applied on a retrospective basis for the periods presented.  Early adoption was permitted.  As of March 31, 2016, the Company has adopted this guidance without a material impact.

The FASB issued an accounting standard update in April 2015 regarding the presentation of debt issuance costs on the balance sheet.  The update requires capitalized debt issuance costs be presented on the balance sheet as a reduction to debt, rather than recorded as a separate asset.  The amendments in this update are effective for annual and interim periods beginning after December 15, 2015 and should be applied on a retrospective basis for the periods presented.  Early adoption was permitted.  Also, in June 2015, the SEC staff announced that the guidance within this accounting standard update was not applicable to revolving debt arrangements or credit facilities.  As of March 31, 2016, the Company has adopted this guidance without a material impact.

The FASB issued an accounting standard update in May 2014 regarding the accounting for and disclosure of revenue recognition.  Specifically, the update outlined a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers, which will be common to both U.S. GAAP and International Financial Reporting Standards (“IFRS”).  The guidance was effective for annual and interim periods beginning after December 15, 2016, and allowed for full retrospective adoption of prior period data or a modified retrospective adoption.  Early adoption was not permitted.  In August 2015, the FASB issued an accounting standard update to delay the effective date of the new revenue standard by one year, or, in other words, to be effective for annual and interim periods beginning after December 15, 2017.  Entities will be permitted to adopt the new revenue standard early but not before the original effective date. In March 2016, the FASB issued an accounting standard update to clarify the implementation guidance on principal versus agent considerations. In April 2016, the FASB issued an accounting standard update to clarify the identification of performance obligations and the licensing implementation guidance, while retaining the related principles for those areas. The amendments in these 2016 updates do not change the core principle of the previously issued guidance in May 2014. The Company is currently evaluating the potential impact of the new revenue recognition guidance and considering the appropriate implementation strategy.

XML

Restructuring and Related Activities

3 Months Ended

Mar. 31, 2016

Restructuring And Related Activities [Abstract]

Restructuring And Related Activities Disclosure [TextBlock]

Note 3 – Restructuring and Related Activities

In response to continued weak economic conditions and market declines in many regions, Quaker’s management approved a global restructuring plan (the “2015 Program”) in the fourth quarter of 2015 to reduce its operating costs. The 2015 Program includes the re-organization of certain commercial functions, the closure of certain distribution, lab and administrative offices, and other related severance charges. In addition to these actions, the Company made a decision to make available for sale certain technology of one of its existing businesses, which also resulted in employee severance and $0.3 million of intangible assets being reclassified to other current assets as of December 31, 2015. During the three months endedMarch 31, 2016, there has been no further update and the intangible assets continue to be available for sale and included in other current assets.

The 2015 Program includes provisions for the reduction of total headcount by approximately 65 employees globally. Employee separation benefits varied depending on local regulations within certain foreign countries and included severance and other benefits. The Company continues to expect to substantially complete all of the initiatives under the 2015 Program during 2016 and expects settlement of these charges to occur primarily in 2016 as well. The Company did not incur additional restructuring expenses in connection with the 2015 Program during the first quarter of 2016, and, at this time, the Company does not expect material, additional restructuring expenses beyond customary and routine adjustments to initial estimates for employee separation benefits.

Restructuring activity recognized in connection with the 2015 Program is as follows:

		North						South
		America		EMEA		Asia/Pacific		America		Total
Accrued restructuring as of
December 31, 2015		$	1,867	$	4,265	$	135	$	36	$	6,303
	Cash payments		(284)		(54)		(132)		(39)		(509)
	Currency translation adjustments		—		175		(3)		3		175
Accrued restructuring as of
March 31, 2016		$	1,583	$	4,386	$	—	$	—	$	5,969

XML

Business Segments

3 Months Ended

Mar. 31, 2016

Segment Reporting Measurement Disclosures [Abstract]

Segment Reporting Disclosure [Text Block]

Note 4 – Business Segments

The Company’s reportable operating segments are organized by geography as follows: (i) North America, (ii) Europe, Middle East and Africa (“EMEA”), (iii) Asia/Pacific and (iv) South America. Operating earnings, excluding indirect operating expenses, for the Company’s reportable operating segments are comprised of revenues less costs of goods sold and selling, general and administrative expenses (“SG&A”) directly related to the respective region’s product sales. The indirect operating expenses consist of SG&A related expenses that are not directly attributable to the product sales of each respective reportable operating segment.Other items not specifically identified with the Company’s reportable operating segments include interest expense, interest income, license fees from non-consolidated affiliates and other income (expense).

The following table presents information about the performance of the Company’s reportable operating segments for the three months endedMarch 31, 2016 and 2015:

		Three Months Ended
		March 31,
		2016		2015
Net sales
	North America	$	82,372	$	83,002
	EMEA		47,649		43,185
	Asia/Pacific		41,512		45,000
	South America		6,544		10,143
Total net sales		$	178,077	$	181,330
Operating earnings, excluding indirect operating expenses
	North America	$	18,632	$	17,825
	EMEA		8,053		6,571
	Asia/Pacific		11,048		10,434
	South America		(315)		1,252
Total operating earnings, excluding indirect operating expenses			37,418		36,082
Indirect operating expenses			(16,407)		(16,591)
Amortization expense			(1,777)		(1,627)
Consolidated operating income			19,234		17,864
Other income (expense), net			706		(194)
Interest expense			(741)		(587)
Interest income			348		320
Consolidated income before taxes and equity in net income of associated companies		$	19,547	$	17,403

Inter-segment revenues for the three months ended March 31, 2016 and 2015 were $1.8 million and $2.0 million for North America, $3.9 million and $4.8 million for EMEA, $0.3 million and $0.1 million for Asia/Pacific, respectively, and less than $0.1 million for South America in both periods. However, all inter-segment transactions have been eliminated from each reportable operating segment’s net sales and earnings for all periods presented above.

XML

Stock-Based Compensation

3 Months Ended

Mar. 31, 2016

Share Based Compensation [Abstract]

Disclosure Of Compensation Related Costs Share Based Payments [Text Block]

Note 5 – Stock-Based Compensation

The Company recognized the following stock-based compensation expense in SG&A in its Condensed Consolidated Statements of Income for the three months endedMarch 31, 2016 and 2015:

	Three Months Ended
	March 31,
	2016		2015
Stock options	$	201	$	185
Nonvested stock awards and restricted stock units		848		752
Employee stock purchase plan		23		18
Non-elective and elective 401(k) matching contribution in stock		689		699
Director stock ownership plan		37		31
Total stock-based compensation expense	$	1,798	$	1,685

The Company’s estimated taxes payable as of March 31, 2016 and 2015, respectively, were sufficient to fully recognize$0.1 million and $0.3 millionof excess tax benefits related to stock option exercises as cash inflows from financing activities in its Condensed Consolidated Statements of Cash Flows, for the three months ended March 31, 2016 and 2015, respectively.

Stock option activity under all plans is as follows:

					Weighted
			Weighted		Average
			Average		Remaining	Aggregate
		Number of	Exercise Price		Contractual	Intrinsic
		Options	(per option)		Term (years)	Value
Options outstanding at December 31, 2015		99,671	$	71.73
	Options granted	67,444		72.12
Options outstanding at March 31, 2016		167,115	$	71.89	5.7	$	2,317
Options expected to vest at March 31, 2016		103,040	$	75.82	6.4	$	1,027
Options exercisable at March 31, 2016		64,075	$	65.57	4.4	$	1,290

There were no options exercised during the three months ended March 31, 2016. The total intrinsic value of options exercised during the three months endedMarch 31, 2015 was $0.2 million.Intrinsic value is calculated as the difference between the current market price of the underlying security and the strike price of a related option.

A summary of the Company’s outstanding stock options at March 31, 2016 is as follows:

						Weighted
						Average	Weighted			Weighted
					Number	Remaining	Average		Number	Average
Range of					of Options	Contractual	Exercise Price		of Options	Exercise Price
Exercise Prices					Outstanding	Term (years)	(per option)		Exercisable	(per option)
$	—	-	$	10.00	—	—	$	—	—	$	—
$	10.01	-	$	20.00	2,367	0.8		18.82	2,367		18.82
$	20.01	-	$	30.00	—	—		—	—		—
$	30.01	-	$	40.00	6,317	2.9		38.13	6,317		38.13
$	40.01	-	$	50.00	—	—		—	—		—
$	50.01	-	$	60.00	21,055	3.9		58.26	21,055		58.26
$	60.01	-	$	70.00	—	—		—	—		—
$	70.01	-	$	80.00	101,230	6.2		72.57	22,281		73.47
$	80.01	-	$	90.00	36,146	5.9		87.30	12,055		87.30
					167,115	5.7		71.89	64,075		65.57

As of March 31, 2016, unrecognized compensation expense related to options granted during 2014, 2015, and 2016 was $0.2 million, $0.5 million, and$1.0 million, respectively.

During the first quarter of 2016, the Company granted stock options under its LTIP plan that are subject only to time vesting over a three-year period. For the purposes of determining the fair value of stock option awards, the Company uses the Black-Scholes option pricing model and the assumptions set forth in the table below:

	2016
Number of options granted	67,444
Dividend yield	1.49	%
Expected volatility	28.39	%
Risk-free interest rate	1.08	%
Expected term (years)	4.0

Less than $0.1millionof expense was recorded on these options during the three months ended March 31, 2016. The fair value of these awards is amortized on a straight-line basis over the vesting period of the awards.

Activity of nonvested shares granted under the Company’s LTIP plan is shown below:

			Weighted
			Average Grant
		Number of	Date Fair Value
		Shares	(per share)
Nonvested awards, December 31, 2015		113,910	$	72.91
	Granted	23,661	$	72.22
	Vested	(17,785)	$	58.97
Nonvested awards, March 31, 2016		119,786	$	74.84

The fair value of the nonvested stock is based on the trading price of the Company’s common stock on the date of grant. The Company adjusts the grant date fair value for expected forfeitures based on historical experience for similar awards. As of March 31, 2016, unrecognized compensation expense related to these awards was $4.5million to be recognized over a weighted average remaining period of 2.0 years.

Activity of nonvested restricted stock units granted under the Company’s LTIP plan is shown below:

			Weighted
			Average Grant
		Number of	Date Fair Value
		Units	(per unit)
Nonvested awards, December 31, 2015		6,174	$	74.14
	Granted	1,841	$	72.12
	Vested	(1,418)	$	58.26
Nonvested awards, March 31, 2016		6,597	$	76.99

The fair value of the nonvested restricted stock units is based on the trading price of the Company’s common stock on the date of grant. The Company adjusts the grant date fair value for expected forfeitures based on historical experience for similar awards. As of March 31, 2016, unrecognized compensation expense related to these awards was $0.2million to be recognized over a weighted average remaining period of 2.1 years.

Employee Stock Purchase Plan

In 2000, the Board adopted an Employee Stock Purchase Plan (“ESPP”) whereby employees may purchase Company stock through a payroll deduction plan. Purchases are made from the plan and credited to each participant’s account at the end of each month (the “Investment Date”). The purchase price of the stock is 85% of the fair market value on the Investment Date. The plan is compensatory and the 15% discount is expensed on the Investment Date. All employees, including officers, are eligible to participate in this plan. A participant may withdraw all uninvested payment balances credited to a participant’s account at any time. An employee whose stock ownership of the Company exceeds five percent of the outstanding common stock is not eligible to participate in this plan.

2013 Director Stock Ownership Plan

In 2013, the Company adopted the 2013 Director Stock Ownership Plan (the “Plan”), to encourage the Directors to increase their investment in the Company, which was approved at the Company’s May 2013 shareholders’ meeting. The Plan authorizes the issuance of up to 75,000 shares of Quaker common stock in accordance with the terms of the Plan in payment of all or a portion of the annual cash retainer payable to each of the Company’s non-employee directors in 2013 and subsequent years during the term of the Plan. Under the Plan, each director who, on May 1of the applicable calendar year, owns less than 400% of the annual cash retainer for the applicable calendar year, divided by the average of the closing price of a share of Quaker Common Stock as reported by the composite tape of the New York Stock Exchange for the previous calendar year (the “Threshold Amount”), is required to receive 75% of the annual cash retainer in Quaker common stock and 25% of the retainer in cash, unless the director elects to receive a greater percentage of Quaker common stock (up to 100%) of the annual cash retainer for the applicable year. Each director who owns more than the Threshold Amount may elect to receive common stock in payment of a percentage (up to 100%) of the annual cash retainer. The annual retainer is $0.1 million and the retainer payment date is June 1.

XML

Pension and Postretirement Benefits

3 Months Ended

Mar. 31, 2016

General Discussion Of Pension And Other Postretirement Benefits [Abstract]

Pension And Other Postretirement Benefits Disclosure [Text Block]

Note 6 – Pension and Other Postretirement Benefits

The components of net periodic benefit cost for the three months endedMarch 31, 2016 and 2015 are as follows:

	Three Months Ended March 31,
					Other
	Pension Benefits				Postretirement Benefits
		2016		2015		2016		2015
Service cost	$	670	$	773	$	4	$	5
Interest cost		1,111		1,262		39		50
Expected return on plan assets		(1,344)		(1,402)		—		—
Actuarial loss amortization		808		881		15		26
Prior service cost amortization		(25)		(26)		—		—
Net periodic benefit cost	$	1,220	$	1,488	$	58	$	81

As of December 31, 2015, the Company elected to use a split discount rate (spot-rate approach) for the U.S. plans and certain foreign plans, which includes the method used to estimate the service and interest components of net periodic benefit cost for pension and other postretirement benefits beginning in the three months ended March 31, 2016.  This change resulted in a decrease in the service and interest components for pension cost in the three months ended March 31, 2016 compared to the three months ended March 31, 2015.  Historically, the Company estimated service and interest cost components utilizing a single weighted-average discount rate derived from a specific yield curve used to measure the benefit obligation at the beginning of the period.  Under the spot-rate approach, service and interest cost components have been estimated based on the application of the spot rates on a given yield curve at each future year to each plan's projected cash flows to measure the benefit obligation at the beginning of the period.  We have made this change to provide a more precise measurement of service and interest costs by improving the correlation between projected benefit cash flows and the corresponding spot yield curve rates.  We have accounted for this as a change in accounting estimate and, accordingly, have accounted for it prospectively.

Employer Contributions

The Company previously disclosed in its financial statements for the year ended December 31, 2015, that it expected to make minimum cash contributions of$7.5 million to its pension plans and$0.5 million to its other postretirement benefit plan in 2016. As of March 31, 2016,$3.6 million and$0.2 millionof contributions have been made to the Company’s pension plans and its postretirement benefit plans, respectively.

XML

Other Income (Expense)

3 Months Ended

Mar. 31, 2016

Other Income And Expenses [Abstract]

Other Income And Other Expense Disclosure [Text Block]

Note 7 – Other Income (Expense), Net

The components of other income (expense), net for the three months endedMarch 31, 2016 and 2015 are as follows:

	Three Months Ended
	March 31,
	2016		2015
Income from third party license fees	$	272	$	254
Foreign exchange gains (losses), net		312		(594)
Gain on fixed asset disposals, net		5		52
Non-income tax refunds and other related credits		21		69
Other non-operating income		124		72
Other non-operating expense		(28)		(47)
Total other income (expense), net	$	706	$	(194)

XML

Income Taxes and Uncertain Tax Positions

3 Months Ended

Mar. 31, 2016

Income Tax Disclosure [Abstract]

Income Tax Disclosure [Text Block]

Note 8 – Income Taxes and Uncertain Income Tax Positions

The Company’s three months endedMarch 31, 2016 effective tax rate was 32.3% compared to three months endedMarch 31, 2015effective tax rate of 30.8%. The increase in the first quarter of 2016 effective tax rate was primarily due to the Company recording earnings in one of its subsidiaries at a statutory tax rate of 25% during the first quarter of 2016, while it awaits recertification of a concessionary 15% tax rate, which was available to the Company during the first quarter of 2015.

As of March 31, 2016, the Company’s cumulative liability for gross unrecognized tax benefits was $11.4 million. At December 31, 2015, the Company’s cumulative liability for gross unrecognized tax benefits was $11.0 million.

The Company continues to recognize interest and penalties associated with uncertain tax positions as a component of taxes on income before equity in net income of associated companies in its Condensed Consolidated Statements of Income. The Company recognized ($0.1) million for interest and less than ($0.1) million for penalties in its Condensed Consolidated Statement of Income for the three months endedMarch 31, 2016, and recognized ($0.2) million for interest and $0.1 million for penalties in its Condensed Consolidated Statement of Income during the three months endedMarch 31, 2015. As of March 31, 2016, the Company had accrued$1.5 million for cumulative interest and $1.9 million for cumulative penalties in its Condensed Consolidated Balance Sheets, compared to $1.5 million for cumulative interest and $1.9 million for cumulative penalties accrued at December 31, 2015.

During the three months ended March 31, 2016 and 2015, the Company recognized a decrease of $0.8 million and $0.7 million, respectively, in its cumulative liability for gross unrecognized tax benefits due to the expiration of the applicable statutes of limitations for certain tax years.

The Company estimates that during the year ending December 31, 2016 it will reduce its cumulative liability for gross unrecognized tax benefits by approximately $1.9 million to $2.0 million due to the expiration of the statute of limitations with regard to certain tax positions. This estimated reduction in the cumulative liability for unrecognized tax benefits does not consider any increase in liability for unrecognized tax benefits with regard to existing tax positions or any increase in cumulative liability for unrecognized tax benefits with regard to new tax positions for the year ending December 31, 2016.

The Company and its subsidiaries are subject to U.S. Federal income tax, as well as the income tax of various state and foreign tax jurisdictions. Tax years that remain subject to examination by major tax jurisdictions include Brazil from 2000, Italy from 2007, France from 2008, the Netherlands and the United Kingdom from 2010, Spain from 2011, China and the United States from 2012, and various domestic state tax jurisdictions from 1993.

The Italian tax authorities have assessed additional tax due from the Company’s subsidiary, Quaker Italia S.r.l., relating to the tax years 2007, 2008, 2009 and 2010. In the first quarter of 2016, the Italian tax authorities delivered an audit report to Quaker Italia S.r.l. for the tax years 2011, 2012 and 2013 alleging additional tax due.In the fourth quarter of 2015, the Dutch tax authorities assessed the Company’s subsidiary, Quaker Chemical B.V., for additional income taxes related to the 2011 tax year and Quaker Chemical B.V. filed a protest of such assessment. In the first quarter of 2016, the French tax authorities gave notice that they were auditing the Company’s subsidiary, Quaker Chemical S.A.As of March 31, 2016, the Company believes it has adequate reserves, where merited, for uncertain tax positions with respect to all of these audits. 

XML

Earnings Per Share

3 Months Ended

Mar. 31, 2016

Earnings Per Share [Abstract]

Earnings Per Share [Text Block]

Note 9 – Earnings Per Share

The following table summarizes earnings per share calculations for the three months endedMarch 31, 2016 and 2015:

		Three Months Ended
		March 31,
		2016		2015
Basic earnings per common share
	Net income attributable to Quaker Chemical Corporation	$	12,946	$	10,378
	Less: income allocated to participating securities		(113)		(96)
	Net income available to common shareholders	$	12,833	$	10,282
	Basic weighted average common shares outstanding		13,116,807		13,188,761
Basic earnings per common share		$	0.98	$	0.78
Diluted earnings per common share
	Net income attributable to Quaker Chemical Corporation	$	12,946	$	10,378
	Less: income allocated to participating securities		(113)		(96)
	Net income available to common shareholders	$	12,833	$	10,282
	Basic weighted average common shares outstanding		13,116,807		13,188,761
	Effect of dilutive securities		12,587		19,896
	Diluted weighted average common shares outstanding		13,129,394		13,208,657
Diluted earnings per common share		$	0.98	$	0.78

The following aggregate numbers of stock options and restricted stock units are not included in the diluted earnings per share calculation since the effect would have been anti-dilutive: 11,742 and 4,497 for the three months ended March 31, 2016 and 2015, respectively.

XML

Goodwill and Intangible Assets

3 Months Ended

Mar. 31, 2016

Goodwill And Intangible Assets Disclosure [Abstract]

Goodwill And Intangible Assets Disclosure [Text Block]

Note 10 – Goodwill and Other Intangible Assets

The Company completes its annual impairment test as of the end of the third quarter of each year, or more frequently if triggering events indicate a possible impairment in one or more of its reporting units. The Company continually evaluates financial performance, economic conditions and other relevant developments in assessing if an interim period impairment test for one or more of its reporting units is necessary. The Company has recorded no impairment charges in its past. Changes in the carrying amount of goodwill for the three months endedMarch 31, 2016 were as follows:

		North						South
		America		EMEA		Asia/Pacific		America		Total
Balance as of December 31, 2015		$	42,443	$	19,280	$	15,244	$	2,144	$	79,111
	Goodwill additions (reductions)		—		(153)		—		—		(153)
	Currency translation adjustments		9		678		165		193		1,045
Balance as of March 31, 2016		$	42,452	$	19,805	$	15,409	$	2,337	$	80,003

Gross carrying amounts and accumulated amortization for definite-lived intangible assets as of March 31, 2016 and December 31, 2015 were as follows:

	Gross Carrying				Accumulated
	Amount				Amortization
	2016		2015		2016		2015
Customer lists and rights to sell	$	68,180	$	67,435	$	17,030	$	15,806
Trademarks and patents		23,533		23,147		6,087		5,538
Formulations and product technology		5,808		5,808		4,128		4,082
Other		5,869		5,788		4,781		4,565
Total definite-lived intangible assets	$	103,390	$	102,178	$	32,026	$	29,991

The Company recorded $1.8 million and $1.6 millionof amortization expense for the three months endedMarch 31, 2016 and 2015, respectively. Estimated annual aggregate amortization expense for the current year and subsequent five years is as follows:

For the year ended December 31, 2016	$	6,895
For the year ended December 31, 2017		6,523
For the year ended December 31, 2018		6,303
For the year ended December 31, 2019		6,201
For the year ended December 31, 2020		5,924
For the year ended December 31, 2021		5,557

The Company has two indefinite-lived intangible assets totaling $1.1 million for trademarks at March 31, 2016 and December 31, 2015.

XML

Debt

3 Months Ended

Mar. 31, 2016

Debt [Abstract]

Debt Disclosure [Text Block]

Note 11 – Debt

The Company’s primary credit facility is a $300.0 million syndicated multicurrency credit agreement with a group of lenders, which matures in June 2018. The maximum amount available under this credit facility can be increased to $400.0 million at the Company’s option if the lenders agree and the Company satisfies certain conditions. Borrowings under this credit facility generally bear interest at a base rate or LIBOR rate plus a margin. Access to this credit facility is dependent on meeting certain financial and other covenants, but primarily depends on the Company’s consolidated leverage ratio calculation, which cannot exceed 3.50 to 1. At March 31, 2016 and December 31, 2015, the Company’s consolidated leverage ratio was below 1.0 to 1, and the Company was also in compliance with all of the other covenants. At March 31, 2016 and December 31, 2015, the Company had$79.1 million and $62.9 million outstanding, respectively, underits credit facilities. The Company’s other debt obligations were primarily industrial development bonds and municipality-related loans as of March 31, 2016 and December 31, 2015.

XML

Equity and Noncontrolling Interest

3 Months Ended

Mar. 31, 2016

Stockholders Equity [Abstract]

Stockholders Equity Note Disclosure [Text Block]

Note 12 – Equity

In May 2015, the Company’s Board of Directors authorized a share repurchase program for the repurchase of up to $100.0 million of Quaker Chemical Corporation common stock (the “2015 Share Repurchase Program”). The 2015 Share Repurchase Program has no expiration date. The 2015 Share Repurchase Program provides a framework of conditions under which management can repurchase shares of the Company’s common stock. The Company intends to repurchase shares to at least offset the dilutive impact of shares issued each year as part of its employee benefit and share based compensation plans, and could repurchase more if the Company considers the share price to be at an amount that it considers an advantageous return for its shareholders. The purchases may be made in the open market or in private and negotiated transactions, in accordance with applicable laws, rules and regulations. In connection with the 2015 Share Repurchase Program, the remaining unutilized 1995 and 2005 Board of Directors authorized share repurchase programs were terminated.

In connection with the 2015 Share Repurchase Program, the Company acquired 83,879 shares of common stock, for $5.9 million, during the three months ended March 31, 2016, and had no repurchases during the three months ended March 31, 2015. The Company has elected not to hold treasury shares, and, therefore, has retired the shares as they are repurchased. It is the Company’s accounting policy to record the excess paid over par value as a reduction in retained earnings for all shares repurchased.

The following tables present the changes in equity, net of tax, for the three months endedMarch 31, 2016 and 2015:

									Accumulated
					Capital in				Other
			Common		Excess of		Retained		Comprehensive		Noncontrolling
			Stock		Par Value		Earnings		Loss		Interest		Total
Balance at December 31, 2015			$	13,288	$	106,333	$	326,740	$	(73,316)	$	8,198	$	381,243
	Net income			—		—		12,946		—		398		13,344
	Amounts reported in other comprehensive
		income		—		—		—		5,314		62		5,376
	Repurchases of common stock			(84)		—		(5,775)		—		—		(5,859)
	Dividends ($0.32 per share)			—		—		(4,227)		—		—		(4,227)
	Share issuance and equity-based compensation
		plans		32		1,513		—		—		—		1,545
	Excess tax benefit from stock option exercises			—		104		—		—		—		104
Balance at March 31, 2016			$	13,236	$	107,950	$	329,684	$	(68,002)	$	8,658	$	391,526
Balance at December 31, 2014			$	13,301	$	99,056	$	299,524	$	(54,406)	$	7,660	$	365,135
	Net income			—		—		10,378		—		229		10,607
	Amounts reported in other comprehensive
		(loss) income		—		—		—		(8,565)		30		(8,535)
	Dividends ($0.30 per share)			—		—		(4,000)		—		—		(4,000)
	Share issuance and equity-based compensation
		plans		31		1,604		—		—		—		1,635
	Excess tax benefit from stock option exercises			—		287		—		—		—		287
Balance at March 31, 2015			$	13,332	$	100,947	$	305,902	$	(62,971)	$	7,919	$	365,129

The following tables show the reclassifications from and resulting balances of accumulated other comprehensive loss (“AOCI”) for the three months endedMarch 31, 2016 and 2015:

							Unrealized
			Currency		Defined		Gain (Loss) in
			Translation		Benefit		Available-for-
			Adjustments		Pension Plans		Sale Securities		Total
Balance at December 31, 2015			$	(38,544)	$	(35,251)	$	479	$	(73,316)
	Other comprehensive income (loss) before
		reclassifications		4,671		(477)		192		4,386
	Amounts reclassified from AOCI			—		798		498		1,296
	Current period other comprehensive income			4,671		321		690		5,682
	Related tax amounts			—		(134)		(234)		(368)
	Net current period other comprehensive income			4,671		187		456		5,314
Balance at March 31, 2016			$	(33,873)	$	(35,064)	$	935	$	(68,002)
Balance at December 31, 2014			$	(14,312)	$	(41,551)	$	1,457	$	(54,406)
	Other comprehensive (loss) income before
		reclassifications		(11,113)		2,498		270		(8,345)
	Amounts reclassified from AOCI			—		881		(164)		717
	Current period other comprehensive (loss) income			(11,113)		3,379		106		(7,628)
	Related tax amounts			—		(901)		(36)		(937)
	Net current period other comprehensive (loss) income			(11,113)		2,478		70		(8,565)
Balance at March 31, 2015			$	(25,425)	$	(39,073)	$	1,527	$	(62,971)

Approximately 70% and 30%of the amounts reclassified from accumulated other comprehensive loss to the Condensed Consolidated Statement of Income for defined benefit retirement plans during the three months ended March 31, 2016 and 2015 were recorded in SG&A and cost of goods sold, respectively. See Note 6 of Notes to Condensed Consolidated Financial Statements for further information. All reclassifications related to unrealized gain (loss) in available-for-sale securities relate to the Company’s equity interest in a captive insurance company and are recorded in equity in net income of associated companies. The amounts reported in other comprehensive income for non-controlling interest are related to currency translation adjustments.

XML

Business Acquisitions

3 Months Ended

Mar. 31, 2016

Business Combinations [Abstract]

Business Combination Disclosure [Text Block]

Note 13 – Business Acquisitions

In July 2015, the Company acquired Verkol, S.A. (“Verkol”), a leading specialty grease and other lubricants manufacturer based in northern Spain, included in its EMEA reportable operating segment, for 37.7 million EUR, or approximately $41.4 million. This includes a post-closing adjustment of 1.3 million EUR, or approximately $1.4 million that was accrued as of December 31, 2015 and paid during the first quarter of 2016. The purchase included cash acquired of 14.1 million EUR, or approximately $15.4 million, and assumed long-term debt of 2.2 million EUR, or approximately $2.4 million.

During the first quarter of 2016, the Company identified and recorded an adjustment to the allocation of the purchase price for the Verkol acquisition. The adjustment was the result of the Company assessing additional information related to assets acquired during the one-year measurement period following the acquisition. As of March 31, 2016, the allocation of the purchase price for the Verkol acquisition has not been finalized and the one-year measurement period has not ended. Further adjustments may be necessary as a result of the Company’s on-going assessment of additional information related to the fair value of assets acquired and liabilities assumed. The following table presents the current allocation of the purchase price of the assets acquired and liabilities assumed:

Verkol Acquisition
Current assets (includes cash acquired)		$	31,151
Property, plant and equipment			7,941
Intangibles
	Customer lists and rights to sell		6,146
	Trademarks and patents		5,378
	Other intangibles		219
Goodwill			5,012
Other long-term assets			158
	Total assets purchased		56,005
Current liabilities			(6,681)
Long-term debt			(2,400)
Other long-term liabilities			(5,531)
	Total liabilities assumed		(14,612)
	Gross cash paid for acquisition	$	41,393
	Less: cash acquired		15,423
	Net cash paid for acquisition	$	25,970

In November 2014, the Company acquired Binol AB, a leading bio-lubricants producer primarily serving the Nordic region, included in its EMEA reportable operating segment, for 136.5 million SEK, or approximately $18.5 million, which is net of 4.4 million SEK, or approximately $0.5 million, received by the Company as part of a post-closing adjustment inthe first quarter of 2015.

The results of operations of the acquired businesses and assets are included in the Condensed Consolidated Statements of Income from their respective acquisition dates.  Transaction expenses associated with these acquisitions are included in SG&A in the Company’s Condensed Consolidated Statements of Income.  Certain pro forma and other information are not presented, as the operations of the acquired businesses are not material to the overall operations of the Company for the periods presented.

XML

Fair Value Measurements

3 Months Ended

Mar. 31, 2016

Fair Value Disclosures [Abstract]

Fair Value Disclosures [Text Block]

Note 14 – Fair Value Measurements

The Company has valued its company-owned life insurance policies at fair value. The Company’s assets subject to fair value measurement were as follows:

			Fair Value Measurements at March 31, 2016
	Total			Using Fair Value Hierarchy
Assets	Fair Value			Level 1		Level 2		Level 3
Company-owned life insurance	$	1,343		$	—	$	1,343	$	—
Total	$	1,343		$	—	$	1,343	$	—

			Fair Value Measurements at December 31, 2015
	Total			Using Fair Value Hierarchy
Assets	Fair Value			Level 1		Level 2		Level 3
Company-owned life insurance	$	1,336		$	—	$	1,336	$	—
Total	$	1,336		$	—	$	1,336	$	—

The fair values of Company-owned life insurance assets are based on quotes for like instruments with similar credit ratings and terms. The Company did not hold any Level 3 investments as of March 31, 2016 or December 31, 2015, respectively, so related disclosures have not been included.

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2016

Commitments And Contingencies Disclosure [Abstract]

Commitments And Contingencies Disclosure [Text Block]

Note 15 – Commitments and Contingencies

In 1992, the Company identified certain soil and groundwater contamination at AC Products, Inc. (“ACP”), a wholly owned subsidiary. In voluntary coordination with the Santa Ana California Regional Water Quality Board (“SACRWQB”), ACP has been remediating the contamination, the principal contaminant of which is perchloroethylene (“PERC”). In 2004, the Orange County Water District (“OCWD”) filed a civil complaint against ACP and other parties seeking to recover compensatory and other damages related to the investigation and remediation of the contamination in the groundwater. Pursuant to a settlement agreement with OCWD, ACP agreed, among other things, to operate the two groundwater treatment systems to hydraulically contain groundwater contamination emanating from ACP’s site until the concentrations of PERC released by ACP fell below the current Federal maximum contaminant level for four consecutive quarterly sampling events. In February 2014, ACPceased operation at one of its two groundwater treatment systems, as it had met the above condition for closure. Based on the most recent modeling, it is estimated that the remaining system will operate for another nine months to thirty three months.

As of March 31, 2016, the Company believes that the range of potential-known liabilities associated with the balance of the ACP water remediation program is approximately $0.2 million to $0.9 million, for which the Company has sufficient reserves. The low and high ends of the range are based on the length of operation of the treatment system as determined by groundwater modeling. Costs of operation include the operation and maintenance of the extraction well, groundwater monitoring and program management.

The Company believes, although there can be no assurance regarding the outcome of other unrelated environmental matters, that it has made adequate accruals for costs associated with other environmental problems of which it is aware. Approximately $0.2 million and $0.3 million was accrued at March 31, 2016 and December 31, 2015, respectively, to provide for such anticipated future environmental assessments and remediation costs.

An inactive subsidiary of the Company that was acquired in 1978 sold certain products containing asbestos, primarily on an installed basis, and is among the defendants in numerous lawsuits alleging injury due to exposure to asbestos. The subsidiary discontinued operations in 1991 and has no remaining assets other than the proceeds received from insurance settlements. To date, the overwhelming majority of these claims have been disposed of without payment and there have been no adverse judgments against the subsidiary. Based on a continued analysis of the existing and anticipated future claims against this subsidiary, it is currently projected that the subsidiary’s total liability over the next 50 years for these claims is less than $3.0 million (excluding costs of defense). Although the Company has also been named as a defendant in certain of these cases, no claims have been actively pursued against the Company, and the Company has not contributed to the defense or settlement of any of these cases pursued against the subsidiary. These cases were handled by the subsidiary’s primary and excess insurers who had agreed in 1997 to pay all defense costs and be responsible for all damages assessed against the subsidiary arising out of existing and future asbestos claims up to the aggregate limits of their policies. A significant portion of this primary insurance coverage was provided by an insurer that is insolvent, and the other primary insurers asserted that the aggregate limits of their policies have been exhausted. The subsidiary challenged the applicability of these limits to the claims being brought against the subsidiary. In response, two of the three carriers entered into separate settlement and release agreements with the subsidiary in 2005 and 2007 for $15.0 million and $20.0 million, respectively. The proceeds of both settlements are restricted and can only be used to pay claims and costs of defense associated with the subsidiary’s asbestos litigation. In 2007, the subsidiary and the remaining primary insurance carrier entered into a Claim Handling and Funding Agreement, under which the carrier is paying 27% of defense and indemnity costs incurred by or on behalf of the subsidiary in connection with asbestos bodily injury claims. The agreement continues until terminated and can only be terminated by either party by providing a minimum of two years prior written notice. As of March 31, 2016, no notice of termination has been given under this agreement. At the end of the term of the agreement, the subsidiary may choose to again pursue its claim against this insurer regarding the application of the policy limits. The Company believes that, if the coverage issues under the primary policies with the remaining carrier are resolved adversely to the subsidiary and all settlement proceeds were used, the subsidiary may have limited additional coverage from a state guarantee fund established following the insolvency of one of the subsidiary’s primary insurers. Nevertheless, liabilities in respect of claims may exceed the assets and coverage available to the subsidiary.

If the subsidiary’s assets and insurance coverage were to be exhausted, claimants of the subsidiary could actively pursue claims against the Company because of the parent-subsidiary relationship. The Company does not believe that such claims would have merit or that the Company would be held to have liability for any unsatisfied obligations of the subsidiary as a result of such claims. After evaluating the nature of the claims filed against the subsidiary and the small number of such claims that have resulted in any payment, the potential availability of additional insurance coverage at the subsidiary level, the additional availability of the Company’s own insurance and the Company’s strong defenses to claims that it should be held responsible for the subsidiary’s obligations because of the parent-subsidiary relationship, the Company believes it is not probable that the Company will incur losses. The Company has been successful to date having claims naming it dismissed during initial proceedings. Since the Company may be in this early stage of litigation for some time, it is not possible to estimate additional losses or range of loss, if any.

As initially disclosed in 2010, one of the Company’s subsidiaries may have paid certain value-added-taxes (“VAT”) incorrectly and, in certain cases, may not have collected sufficient VAT from certain customers. The VAT rules and regulations at issue are complex, vary among the jurisdictions and can be contradictory, in particular as to how they relate to the subsidiary’s products and to sales between jurisdictions.Since its inception, the subsidiary had been consistent in its VAT collection and remittance practices and had never been contacted by any tax authority relative to VAT. The subsidiary later determined that for certain products, a portion of the VAT was incorrectly paid and that the total VAT due exceeded the amount originally collected and remitted by the subsidiary. In response, the subsidiary modified its VAT invoicing and payment procedures to eliminate or mitigate future exposure.

In 2010, three jurisdictions contacted the subsidiary and, since then, the subsidiary has either participated in an amnesty program or entered into a settlement whereby it paid a reduced portion of the amounts owed in resolution of those jurisdictions’ claims. In 2013, an additional jurisdiction issued an assessment against the subsidiary for certain tax years. During the fourth quarter of 2015, the subsidiary participated in an amnesty program whereby it paid a reduced portion of the amounts owed in resolution of the jurisdictions’ claims. As a result, the Company had no remaining accruals for these or any other related tax assessments at March 31, 2016 or December 31, 2015.

In analyzing the subsidiary’s exposure, it is difficult to estimate both the probability and the amount of any potential liabilities due to a number of factors, including: the decrease in exposure over time due to applicable statutes of limitations and actions taken by the subsidiary, the joint liability of customers and suppliers for a portion of the VAT, the availability of a VAT refund for VAT incorrectly paid through an administrative process, any amounts which may have been or will be paid by customers, as well as the timing and structure of any tax amnesties or settlements. In addition, interest and penalties on any VAT due can be a multiple of the base tax. The subsidiary may contest any tax assessment administratively and/or judicially for an extended period of time, but may ultimately resolve its disputes through participation in tax amnesty programs, which are a common practice for settling tax disputes in the jurisdictions in question and which have historically occurred on a regular basis, resulting in significant reductions of interest and penalties. Also, the timing of payments and refunds of VAT may not be contemporaneous, and, if additional VAT is owed, it may not be fully recoverable from customers. As of March 31, 2016, the Company believes there is one potentially impacted jurisdiction remaining, and if the jurisdiction were to initiate audits and issue assessments, the remaining exposure, net of refunds, could be from $0 million to $1.0 million, assuming the continued availability of future amnesty programs or settlements to reduce the interest and penalties. If there are future assessments but no such future amnesty programs or settlements, the potential exposure could be higher.

The Company is party to other litigation which management currently believes will not have a material adverse effect on the Company’s results of operations, cash flows or financial condition.

XML

Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2016

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Basis Of Accounting Policy [Policy Text Block]

The condensed consolidated financial statements included herein are unaudited and have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial reporting and the United States Securities and Exchange Commission (“SEC”) regulations. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the financial statements reflect all adjustments (consisting only of normal recurring adjustments, except certain material adjustments, as discussed below) which are necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods. The results for the three months endedMarch 31, 2016 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2015.

Revenue Recognition Accounting Policy, Gross and Net Revenue Disclosure [Policy Text Block]

As part of the Company’s chemical management services, certain third-party product sales to customers are managed by the Company. Where the Company acts as the principal, revenue is recognized on a gross reporting basis at the selling price negotiated with customers. Where the Company acts as an agent, such revenue is recorded using net reporting of service revenue, at the amount of the administrative fee earned by the Company for ordering the goods.

Goodwill And Intangible Assets, Goodwill, Policy [Policy Text Block]

The Company completes its annual impairment test as of the end of the third quarter of each year, or more frequently if triggering events indicate a possible impairment in one or more of its reporting units. The Company continually evaluates financial performance, economic conditions and other relevant developments in assessing if an interim period impairment test for one or more of its reporting units is necessary.

XML

Restructuring Activities (Tables)

3 Months Ended

Mar. 31, 2016

Restructuring And Related Activities [Abstract]

Restructuring and Related Costs [Table Text Block]

		North						South
		America		EMEA		Asia/Pacific		America		Total
Accrued restructuring as of
December 31, 2015		$	1,867	$	4,265	$	135	$	36	$	6,303
	Cash payments		(284)		(54)		(132)		(39)		(509)
	Currency translation adjustments		—		175		(3)		3		175
Accrued restructuring as of
March 31, 2016		$	1,583	$	4,386	$	—	$	—	$	5,969

XML

Business Segments (Tables)

3 Months Ended

Mar. 31, 2016

Segment Reporting Measurement Disclosures [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

		Three Months Ended
		March 31,
		2016		2015
Net sales
	North America	$	82,372	$	83,002
	EMEA		47,649		43,185
	Asia/Pacific		41,512		45,000
	South America		6,544		10,143
Total net sales		$	178,077	$	181,330
Operating earnings, excluding indirect operating expenses
	North America	$	18,632	$	17,825
	EMEA		8,053		6,571
	Asia/Pacific		11,048		10,434
	South America		(315)		1,252
Total operating earnings, excluding indirect operating expenses			37,418		36,082
Indirect operating expenses			(16,407)		(16,591)
Amortization expense			(1,777)		(1,627)
Consolidated operating income			19,234		17,864
Other income (expense), net			706		(194)
Interest expense			(741)		(587)
Interest income			348		320
Consolidated income before taxes and equity in net income of associated companies		$	19,547	$	17,403

XML

Stock Based Compensation (Tables)

3 Months Ended

Mar. 31, 2016

Share Based Compensation [Abstract]

Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]

	Three Months Ended
	March 31,
	2016		2015
Stock options	$	201	$	185
Nonvested stock awards and restricted stock units		848		752
Employee stock purchase plan		23		18
Non-elective and elective 401(k) matching contribution in stock		689		699
Director stock ownership plan		37		31
Total stock-based compensation expense	$	1,798	$	1,685

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

					Weighted
			Weighted		Average
			Average		Remaining	Aggregate
		Number of	Exercise Price		Contractual	Intrinsic
		Options	(per option)		Term (years)	Value
Options outstanding at December 31, 2015		99,671	$	71.73
	Options granted	67,444		72.12
Options outstanding at March 31, 2016		167,115	$	71.89	5.7	$	2,317
Options expected to vest at March 31, 2016		103,040	$	75.82	6.4	$	1,027
Options exercisable at March 31, 2016		64,075	$	65.57	4.4	$	1,290

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]

						Weighted
						Average	Weighted			Weighted
					Number	Remaining	Average		Number	Average
Range of					of Options	Contractual	Exercise Price		of Options	Exercise Price
Exercise Prices					Outstanding	Term (years)	(per option)		Exercisable	(per option)
$	—	-	$	10.00	—	—	$	—	—	$	—
$	10.01	-	$	20.00	2,367	0.8		18.82	2,367		18.82
$	20.01	-	$	30.00	—	—		—	—		—
$	30.01	-	$	40.00	6,317	2.9		38.13	6,317		38.13
$	40.01	-	$	50.00	—	—		—	—		—
$	50.01	-	$	60.00	21,055	3.9		58.26	21,055		58.26
$	60.01	-	$	70.00	—	—		—	—		—
$	70.01	-	$	80.00	101,230	6.2		72.57	22,281		73.47
$	80.01	-	$	90.00	36,146	5.9		87.30	12,055		87.30
					167,115	5.7		71.89	64,075		65.57

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

	2016
Number of options granted	67,444
Dividend yield	1.49	%
Expected volatility	28.39	%
Risk-free interest rate	1.08	%
Expected term (years)	4.0

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]

			Weighted
			Average Grant
		Number of	Date Fair Value
		Shares	(per share)
Nonvested awards, December 31, 2015		113,910	$	72.91
	Granted	23,661	$	72.22
	Vested	(17,785)	$	58.97
Nonvested awards, March 31, 2016		119,786	$	74.84

			Weighted
			Average Grant
		Number of	Date Fair Value
		Units	(per unit)
Nonvested awards, December 31, 2015		6,174	$	74.14
	Granted	1,841	$	72.12
	Vested	(1,418)	$	58.26
Nonvested awards, March 31, 2016		6,597	$	76.99

XML

Pension and Postretirement Benefits (Tables)

3 Months Ended

Mar. 31, 2016

General Discussion Of Pension And Other Postretirement Benefits [Abstract]

Schedule of Defined Benefit Plans Disclosures [Table Text Block]

	Three Months Ended March 31,
					Other
	Pension Benefits				Postretirement Benefits
		2016		2015		2016		2015
Service cost	$	670	$	773	$	4	$	5
Interest cost		1,111		1,262		39		50
Expected return on plan assets		(1,344)		(1,402)		—		—
Actuarial loss amortization		808		881		15		26
Prior service cost amortization		(25)		(26)		—		—
Net periodic benefit cost	$	1,220	$	1,488	$	58	$	81

XML

Other Income (Expense) (Tables)

3 Months Ended

Mar. 31, 2016

Other Income And Expenses [Abstract]

Schedule Of Other Nonoperating Income (Expense) [Table Text Block]

	Three Months Ended
	March 31,
	2016		2015
Income from third party license fees	$	272	$	254
Foreign exchange gains (losses), net		312		(594)
Gain on fixed asset disposals, net		5		52
Non-income tax refunds and other related credits		21		69
Other non-operating income		124		72
Other non-operating expense		(28)		(47)
Total other income (expense), net	$	706	$	(194)

XML

Earnings Per Share (Tables)

3 Months Ended

Mar. 31, 2016

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

		Three Months Ended
		March 31,
		2016		2015
Basic earnings per common share
	Net income attributable to Quaker Chemical Corporation	$	12,946	$	10,378
	Less: income allocated to participating securities		(113)		(96)
	Net income available to common shareholders	$	12,833	$	10,282
	Basic weighted average common shares outstanding		13,116,807		13,188,761
Basic earnings per common share		$	0.98	$	0.78
Diluted earnings per common share
	Net income attributable to Quaker Chemical Corporation	$	12,946	$	10,378
	Less: income allocated to participating securities		(113)		(96)
	Net income available to common shareholders	$	12,833	$	10,282
	Basic weighted average common shares outstanding		13,116,807		13,188,761
	Effect of dilutive securities		12,587		19,896
	Diluted weighted average common shares outstanding		13,129,394		13,208,657
Diluted earnings per common share		$	0.98	$	0.78

XML

Goodwill and Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2016

Goodwill And Intangible Assets Disclosure [Abstract]

Schedule of Goodwill [Table Text Block]

		North						South
		America		EMEA		Asia/Pacific		America		Total
Balance as of December 31, 2015		$	42,443	$	19,280	$	15,244	$	2,144	$	79,111
	Goodwill additions (reductions)		—		(153)		—		—		(153)
	Currency translation adjustments		9		678		165		193		1,045
Balance as of March 31, 2016		$	42,452	$	19,805	$	15,409	$	2,337	$	80,003

Schedule Of Finite Lived Intangible Assets [Table Text Block]

	Gross Carrying				Accumulated
	Amount				Amortization
	2016		2015		2016		2015
Customer lists and rights to sell	$	68,180	$	67,435	$	17,030	$	15,806
Trademarks and patents		23,533		23,147		6,087		5,538
Formulations and product technology		5,808		5,808		4,128		4,082
Other		5,869		5,788		4,781		4,565
Total definite-lived intangible assets	$	103,390	$	102,178	$	32,026	$	29,991

Schedule of Finite Lived Intangible Assets Future Amortization Expense [TableText Block]

For the year ended December 31, 2016	$	6,895
For the year ended December 31, 2017		6,523
For the year ended December 31, 2018		6,303
For the year ended December 31, 2019		6,201
For the year ended December 31, 2020		5,924
For the year ended December 31, 2021		5,557

XML

Equity and Noncontrolling Interest (Tables)

3 Months Ended

Mar. 31, 2016

Stockholders Equity [Abstract]

Schedule of Stockholders Equity [Table Text Block]

									Accumulated
					Capital in				Other
			Common		Excess of		Retained		Comprehensive		Noncontrolling
			Stock		Par Value		Earnings		Loss		Interest		Total
Balance at December 31, 2015			$	13,288	$	106,333	$	326,740	$	(73,316)	$	8,198	$	381,243
	Net income			—		—		12,946		—		398		13,344
	Amounts reported in other comprehensive
		income		—		—		—		5,314		62		5,376
	Repurchases of common stock			(84)		—		(5,775)		—		—		(5,859)
	Dividends ($0.32 per share)			—		—		(4,227)		—		—		(4,227)
	Share issuance and equity-based compensation
		plans		32		1,513		—		—		—		1,545
	Excess tax benefit from stock option exercises			—		104		—		—		—		104
Balance at March 31, 2016			$	13,236	$	107,950	$	329,684	$	(68,002)	$	8,658	$	391,526
Balance at December 31, 2014			$	13,301	$	99,056	$	299,524	$	(54,406)	$	7,660	$	365,135
	Net income			—		—		10,378		—		229		10,607
	Amounts reported in other comprehensive
		(loss) income		—		—		—		(8,565)		30		(8,535)
	Dividends ($0.30 per share)			—		—		(4,000)		—		—		(4,000)
	Share issuance and equity-based compensation
		plans		31		1,604		—		—		—		1,635
	Excess tax benefit from stock option exercises			—		287		—		—		—		287
Balance at March 31, 2015			$	13,332	$	100,947	$	305,902	$	(62,971)	$	7,919	$	365,129

Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]

							Unrealized
			Currency		Defined		Gain (Loss) in
			Translation		Benefit		Available-for-
			Adjustments		Pension Plans		Sale Securities		Total
Balance at December 31, 2015			$	(38,544)	$	(35,251)	$	479	$	(73,316)
	Other comprehensive income (loss) before
		reclassifications		4,671		(477)		192		4,386
	Amounts reclassified from AOCI			—		798		498		1,296
	Current period other comprehensive income			4,671		321		690		5,682
	Related tax amounts			—		(134)		(234)		(368)
	Net current period other comprehensive income			4,671		187		456		5,314
Balance at March 31, 2016			$	(33,873)	$	(35,064)	$	935	$	(68,002)
Balance at December 31, 2014			$	(14,312)	$	(41,551)	$	1,457	$	(54,406)
	Other comprehensive (loss) income before
		reclassifications		(11,113)		2,498		270		(8,345)
	Amounts reclassified from AOCI			—		881		(164)		717
	Current period other comprehensive (loss) income			(11,113)		3,379		106		(7,628)
	Related tax amounts			—		(901)		(36)		(937)
	Net current period other comprehensive (loss) income			(11,113)		2,478		70		(8,565)
Balance at March 31, 2015			$	(25,425)	$	(39,073)	$	1,527	$	(62,971)

XML

Business Acquisitions (Tables)

3 Months Ended

Mar. 31, 2016

Business Combinations [Abstract]

Schedule of Business Acquisitions, by Acquisition [Table Text Block]

Verkol Acquisition
Current assets (includes cash acquired)		$	31,151
Property, plant and equipment			7,941
Intangibles
	Customer lists and rights to sell		6,146
	Trademarks and patents		5,378
	Other intangibles		219
Goodwill			5,012
Other long-term assets			158
	Total assets purchased		56,005
Current liabilities			(6,681)
Long-term debt			(2,400)
Other long-term liabilities			(5,531)
	Total liabilities assumed		(14,612)
	Gross cash paid for acquisition	$	41,393
	Less: cash acquired		15,423
	Net cash paid for acquisition	$	25,970

XML

Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2016

Fair Value Disclosures [Abstract]

Fair Value, Assets Measured on Recurring Basis [Table Text Block]

			Fair Value Measurements at March 31, 2016
	Total			Using Fair Value Hierarchy
Assets	Fair Value			Level 1		Level 2		Level 3
Company-owned life insurance	$	1,343		$	—	$	1,343	$	—
Total	$	1,343		$	—	$	1,343	$	—

			Fair Value Measurements at December 31, 2015
	Total			Using Fair Value Hierarchy
Assets	Fair Value			Level 1		Level 2		Level 3
Company-owned life insurance	$	1,336		$	—	$	1,336	$	—
Total	$	1,336		$	—	$	1,336	$	—

XML

Condensed Financial Information (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Schedule of Equity Method Investments [Line Items]
Equity Method Investment	$ 21,194		$ 20,354
Prior Period Reclassification Adjustment	3,600
Revenue Recognized Under Net Reporting Arrangements	11,100	$ 11,900
Kelko (Venezuela) [Member]
Schedule of Equity Method Investments [Line Items]
Effect Of Currency Conversion, Amount	$ 100	$ 2,800
Effect Of Currency Conversion, Per Diluted Share	$ 0.01	$ 0.21
Equity Method Investment	$ 200		$ 200

XML

Condensed Financial Information - Foreign currency (Details) - VEF / $	Mar. 31, 2016	Dec. 31, 2015	Mar. 31, 2015	Dec. 31, 2014
CADIVI [Member]
Schedule of Foreign Currency [Line Items]
Venezuela Currency exchange rate				6.3
SIMADI [Member]
Schedule of Foreign Currency [Line Items]
Venezuela Currency exchange rate		198	193
DIPRO [Member]
Schedule of Foreign Currency [Line Items]
Venezuela Currency exchange rate	10
DICOM [Member]
Schedule of Foreign Currency [Line Items]
Venezuela Currency exchange rate	273

XML

Restructuring Activities - Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Restructuring And Related Activities [Abstract]
Intangible Assets Reclassified as Held for Sale	$ 0.3	$ 0.3

XML

Restructuring Activities (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2016 USD ($)
Restructuring Reserve [Roll Forward]
Accrued Restructuring, Beginning Balance	$ 6,303
Cash Payments	(509)
Currency Translation Adjustments	175
Accrued Restructuring, Ending Balance	5,969
North America [Member]
Restructuring Reserve [Roll Forward]
Accrued Restructuring, Beginning Balance	1,867
Cash Payments	(284)
Currency Translation Adjustments	0
Accrued Restructuring, Ending Balance	1,583
EMEA [Member]
Restructuring Reserve [Roll Forward]
Accrued Restructuring, Beginning Balance	4,265
Cash Payments	(54)
Currency Translation Adjustments	175
Accrued Restructuring, Ending Balance	4,386
Asia Pacific [Member]
Restructuring Reserve [Roll Forward]
Accrued Restructuring, Beginning Balance	135
Cash Payments	(132)
Currency Translation Adjustments	(3)
Accrued Restructuring, Ending Balance	0
South America [Member]
Restructuring Reserve [Roll Forward]
Accrued Restructuring, Beginning Balance	36
Cash Payments	(39)
Currency Translation Adjustments	3
Accrued Restructuring, Ending Balance	$ 0

XML

Business Segments (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Segment Reporting Information [Line Items]
Net Sales	$ 178,077	$ 181,330
Operating Earnings, Excluding Indirect Operating Expenses	37,418	36,082
Reconciliation from Segment Totals to Consolidated [Abstract]
Indirect Operating Expenses	(16,407)	(16,591)
Amortization	(1,777)	(1,627)
Operating income	19,234	17,864
Other income (expense), net	706	(194)
Interest Expense	(741)	(587)
Interest Income	348	320
Income Before Taxes and Equity in Net Income of Associated Companies	19,547	17,403
North America [Member]
Segment Reporting Information [Line Items]
Net Sales	82,372	83,002
Operating Earnings, Excluding Indirect Operating Expenses	18,632	17,825
North America [Member] | Intersegment Sales Elimination [Member]
Segment Reporting Information [Line Items]
Net Sales	1,800	2,000
EMEA [Member]
Segment Reporting Information [Line Items]
Net Sales	47,649	43,185
Operating Earnings, Excluding Indirect Operating Expenses	8,053	6,571
EMEA [Member] | Intersegment Sales Elimination [Member]
Segment Reporting Information [Line Items]
Net Sales	3,900	4,800
Asia Pacific [Member]
Segment Reporting Information [Line Items]
Net Sales	41,512	45,000
Operating Earnings, Excluding Indirect Operating Expenses	11,048	10,434
Asia Pacific [Member] | Intersegment Sales Elimination [Member]
Segment Reporting Information [Line Items]
Net Sales	300	100
South America [Member]
Segment Reporting Information [Line Items]
Net Sales	6,544	10,143
Operating Earnings, Excluding Indirect Operating Expenses	(315)	1,252
South America [Member] | Intersegment Sales Elimination [Member]
Segment Reporting Information [Line Items]
Net Sales	$ 100	$ 100

XML

Stock Based Compensation - Expense Table (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Allocated Share-based Compensation Expense	$ 1,798	$ 1,685
Stock Options Compensation Expense [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Allocated Share-based Compensation Expense	201	185
Nonvested Stock Awards and Restricted Stock Unit Compensation Expense [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Allocated Share-based Compensation Expense	848	752
Employee Stock Purchase Plan Compensation Expense [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Allocated Share-based Compensation Expense	23	18
401 (k) Matching Stock Contribution Plan Compensation Expense [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Allocated Share-based Compensation Expense	689	699
Directors Stock Ownership Plan Compensation Expense [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Allocated Share-based Compensation Expense	$ 37	$ 31

XML

Stock Based Compensation - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Share Based Compensation [Abstract]
Exercised Options, Instrinsic Value	$ 0	$ 200
Option Award Vesting Period	3 years
Share Based Compensation [Line Items]
Share-based Compensation Expense in Period, Stock Option Awards	$ 1,798	$ 1,685
ESPP: Purchase Price Percentage	85.00%
ESPP: Discount from Market Price	15.00%
ESPP: Maximum Ownership of Outstanding Shares	An employee whose stock ownership of the Company exceeds five percent of the outstanding common stock is not eligible to participate in this plan.
D S O P 2013 [Member]
Share Based Compensation [Line Items]
Director Stock Ownership Plan Maximum Number of Shares Authorized Under Plan	75,000
Director Stock Ownership Plan Terms	Under the Plan, each director who, on May 1 of the applicable calendar year, owns less than 400% of the annual cash retainer for the applicable calendar year, divided by the average of the closing price of a share of Quaker Common Stock as reported by the composite tape of the New York Stock Exchange for the previous calendar year (the “Threshold Amount”), is required to receive 75% of the annual cash retainer in Quaker common stock and 25% of the retainer in cash, unless the director elects to receive a greater percentage of Quaker common stock (up to 100%) of the annual cash retainer for the applicable year. Each director who owns more than the Threshold Amount may elect to receive common stock in payment of a percentage (up to 100%) of the annual cash retainer.
Director Retainer Annual Fee	$ 100
Options Granted in Current Year [Member]
Share Based Compensation [Line Items]
Share-based Compensation Expense in Period, Stock Option Awards	100
Unrecognized Share-Based Compensation Expense, Stock Option Awards	1,000
Options Granted in Previous Year [Member]
Share Based Compensation [Line Items]
Unrecognized Share-Based Compensation Expense, Stock Option Awards	500
Options Granted in Second Previous Year [Member]
Share Based Compensation [Line Items]
Unrecognized Share-Based Compensation Expense, Stock Option Awards	200
Restricted Stock LTIP Plan [Member]
Share Based Compensation [Line Items]
Unrecognized Share-based Compensation Expense, Nonvested Stock Award	$ 4,500
Weighted Average Remaining Life, Nonvested Stock Awards	2 years
Restricted Stock Units (RSUs) LTIP Plan [Member]
Share Based Compensation [Line Items]
Unrecognized Share-based Compensation Expense, Nonvested Stock Award	$ 200
Weighted Average Remaining Life, Nonvested Stock Awards	2 years 1 month

XML

Stock Based Compensation - Excess Tax Benefit (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Share Based Compensation [Abstract]
Excess Tax Benefit From Stock Option Exercises	$ 104	$ 287
Excess tax benefit related to stock option exercises, cash flow	$ 104	$ 287

XML

Stock Based Compensation - Options Grant (Details)	3 Months Ended
	Mar. 31, 2016 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Granted	67,444
Dividend Yield	1.49%
Expected Volatility	28.39%
Risk-free Interest Rate	1.08%
Expected Term (Years)	4 years

XML

Stock Based Compensation - Options Rollforward (Details) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2016 USD ($) $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Beginning Balance | shares	99,671
Options Granted | shares	67,444
Ending Balance | shares	167,115
Options Expected to Vest | shares	103,040
Options Exerciseable | shares	64,075
Weighted Average Exercise Price [Abstract]
Outstanding at Beginning of Year | $ / shares	$ 71.73
Options Granted | $ / shares	72.12
Outstanding at End of Period | $ / shares	71.89
Options Expected to Vest | $ / shares	75.82
Options Exercisable | $ / shares	$ 65.57
Weighted Average Contractual Term [Abstract]
Weighted Average Remaining Contractual Term, Outstanding	5 years 8 months
Weighted Average Remaining Contractual Term, Expected to Vest	6 years 5 months
Weighted Average Remaining Contractual Term, Exercisable	4 years 5 months
Outstanding Options, Intrinsic Value | $	$ 2,317
Expected to Vest Options, Intrinsic Value | $	1,027
Exercisable Options, Intrinsic Value | $	$ 1,290

XML

Stock Based Compensation - Options Summary (Details)	3 Months Ended
	Mar. 31, 2016 $ / shares shares
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number of Outstanding Options, Exercise Price Range | shares	167,115
Weighted Average Contractual Life, Outstanding Options, Exercise Price Range	5 years 8 months
Weighted Average Exercise Price, Outstanding Options, Exercise Price Range	$ 71.89
Number of Exercisable Options, Exercise Price Range | shares	64,075
Weighted Average Exercise Price, Exercisable Options, Exercise Price Range	$ 65.57
$0.00 - $10.00
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Range, Lower Range Limit	0
Exercise Price Range, Upper Range Limit	$ 10
Number of Outstanding Options, Exercise Price Range | shares	0
Weighted Average Contractual Life, Outstanding Options, Exercise Price Range	0 years
Weighted Average Exercise Price, Outstanding Options, Exercise Price Range	$ 0
Number of Exercisable Options, Exercise Price Range | shares	0
Weighted Average Exercise Price, Exercisable Options, Exercise Price Range	$ 0
$10.01 - $20.00
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Range, Lower Range Limit	10.01
Exercise Price Range, Upper Range Limit	$ 20
Number of Outstanding Options, Exercise Price Range | shares	2,367
Weighted Average Contractual Life, Outstanding Options, Exercise Price Range	10 months
Weighted Average Exercise Price, Outstanding Options, Exercise Price Range	$ 18.82
Number of Exercisable Options, Exercise Price Range | shares	2,367
Weighted Average Exercise Price, Exercisable Options, Exercise Price Range	$ 18.82
$20.01 - $30.00
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Range, Lower Range Limit	20.01
Exercise Price Range, Upper Range Limit	$ 30
Number of Outstanding Options, Exercise Price Range | shares	0
Weighted Average Contractual Life, Outstanding Options, Exercise Price Range	0 years
Weighted Average Exercise Price, Outstanding Options, Exercise Price Range	$ 0
Number of Exercisable Options, Exercise Price Range | shares	0
Weighted Average Exercise Price, Exercisable Options, Exercise Price Range	$ 0
$30.01 - $40.00
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Range, Lower Range Limit	30.01
Exercise Price Range, Upper Range Limit	$ 40
Number of Outstanding Options, Exercise Price Range | shares	6,317
Weighted Average Contractual Life, Outstanding Options, Exercise Price Range	2 years 11 months
Weighted Average Exercise Price, Outstanding Options, Exercise Price Range	$ 38.13
Number of Exercisable Options, Exercise Price Range | shares	6,317
Weighted Average Exercise Price, Exercisable Options, Exercise Price Range	$ 38.13
$40.01 - $50.00
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Range, Lower Range Limit	40.01
Exercise Price Range, Upper Range Limit	$ 50
Number of Outstanding Options, Exercise Price Range | shares	0
Weighted Average Contractual Life, Outstanding Options, Exercise Price Range	0 years
Weighted Average Exercise Price, Outstanding Options, Exercise Price Range	$ 0
Number of Exercisable Options, Exercise Price Range | shares	0
Weighted Average Exercise Price, Exercisable Options, Exercise Price Range	$ 0
$50.01 - $60.00
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Range, Lower Range Limit	50.01
Exercise Price Range, Upper Range Limit	$ 60
Number of Outstanding Options, Exercise Price Range | shares	21,055
Weighted Average Contractual Life, Outstanding Options, Exercise Price Range	3 years 11 months
Weighted Average Exercise Price, Outstanding Options, Exercise Price Range	$ 58.26
Number of Exercisable Options, Exercise Price Range | shares	21,055
Weighted Average Exercise Price, Exercisable Options, Exercise Price Range	$ 58.26
$60.01 - $70.00
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Range, Lower Range Limit	60.01
Exercise Price Range, Upper Range Limit	$ 70
Number of Outstanding Options, Exercise Price Range | shares	0
Weighted Average Contractual Life, Outstanding Options, Exercise Price Range	0 years
Weighted Average Exercise Price, Outstanding Options, Exercise Price Range	$ 0
Number of Exercisable Options, Exercise Price Range | shares	0
Weighted Average Exercise Price, Exercisable Options, Exercise Price Range	$ 0
$70.01 - $80.00
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Range, Lower Range Limit	70.01
Exercise Price Range, Upper Range Limit	$ 80
Number of Outstanding Options, Exercise Price Range | shares	101,230
Weighted Average Contractual Life, Outstanding Options, Exercise Price Range	6 years 2 months
Weighted Average Exercise Price, Outstanding Options, Exercise Price Range	$ 72.57
Number of Exercisable Options, Exercise Price Range | shares	22,281
Weighted Average Exercise Price, Exercisable Options, Exercise Price Range	$ 73.47
$80.01 - $90.00
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Range, Lower Range Limit	80.01
Exercise Price Range, Upper Range Limit	$ 90
Number of Outstanding Options, Exercise Price Range | shares	36,146
Weighted Average Contractual Life, Outstanding Options, Exercise Price Range	5 years 11 months
Weighted Average Exercise Price, Outstanding Options, Exercise Price Range	$ 87.3
Number of Exercisable Options, Exercise Price Range | shares	12,055
Weighted Average Exercise Price, Exercisable Options, Exercise Price Range	$ 87.3

XML

Stock Based Compensation - Restricted Stock Rollforward (Details)	3 Months Ended
	Mar. 31, 2016 $ / shares shares
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]
Beginning Balance | shares	113,910
Nonvested Stock Awards Granted | shares	23,661
Nonvested Stock Awards Vested | shares	(17,785)
Ending Balance | shares	119,786
Weighted Average Grant Date Fair Value, Nonvested Stock Awards, Beginning of Period | $ / shares	$ 72.91
Weighted Average Grant Date Fair Value, Nonvested Stock Awards Granted | $ / shares	72.22
Weighted Average Grant Date Fair Value, Nonvested Stock Awards Vested | $ / shares	58.97
Weighted Average Grant Date Fair Value, Nonvested Stock Awards, End of Period | $ / shares	$ 74.84
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]
Beginning Balance | shares	6,174
Nonvested Stock Awards Granted | shares	1,841
Nonvested Stock Awards Vested | shares	(1,418)
Ending Balance | shares	6,597
Weighted Average Grant Date Fair Value, Nonvested Stock Awards, Beginning of Period | $ / shares	$ 74.14
Weighted Average Grant Date Fair Value, Nonvested Stock Awards Granted | $ / shares	72.12
Weighted Average Grant Date Fair Value, Nonvested Stock Awards Vested | $ / shares	58.26
Weighted Average Grant Date Fair Value, Nonvested Stock Awards, End of Period | $ / shares	$ 76.99

XML

Pension and Postretirement Benefits (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Pension Plans, Defined Benefit [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Service Cost	$ 670	$ 773
Defined Benefit Plan, Interest Cost	1,111	1,262
Defined Benefit Plan, Expected Return on Plan Assets	(1,344)	(1,402)
Defined Benefit Plan, Amortization of Losses	808	881
Defined Benefit Plan, Amortization of Prior Service Cost	(25)	(26)
Defined Benefit Plan, Net Periodic Benefit Cost	1,220	1,488
Defined Benefit Plan, Estimated Future Employer Contributions in Current Fiscal Year	7,500
Defined Benefit Plan, Contributions by Employer	3,600
Other Postretirement Benefit Plans, Defined Benefit [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Service Cost	4	5
Defined Benefit Plan, Interest Cost	39	50
Defined Benefit Plan, Expected Return on Plan Assets	0	0
Defined Benefit Plan, Amortization of Losses	15	26
Defined Benefit Plan, Amortization of Prior Service Cost	0	0
Defined Benefit Plan, Net Periodic Benefit Cost	58	$ 81
Defined Benefit Plan, Estimated Future Employer Contributions in Current Fiscal Year	500
Defined Benefit Plan, Contributions by Employer	$ 200

XML

Other Income (Expense) - (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Other Income And Expenses [Abstract]
Income From Third Party License Fees	$ 272	$ 254
Foreign Exchange Gains (Losses), Net	312	(594)
Gain on Fixed Asset Disposals, Net	5	52
Non-Income Tax Refunds and Other Related Credits	21	69
Other Nonoperating Income	124	72
Other Nonoperating Expense	(28)	(47)
Other Income (Expense), Net	$ 706	$ (194)

XML

Income Taxes and Uncertain Tax Positions (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Effective Income Tax Rate, Continuing Operations	32.30%	30.80%
Unrecognized Tax Benefits	$ 11.4		$ 11.0
Unrecognized Tax Benefits, Interest on Income Taxes Expense	(0.1)	$ (0.2)
Unrecognized Tax Benefits, Income Tax Penalties Expense	(0.1)	0.1
Unrecognized Tax Benefits, Interest on Income Taxes Accrued	1.5		1.5
Unrecognized Tax Benefits, Income Tax Penalties Accrued	1.9		$ 1.9
Tax Adjustments, Settlements, and Unusual Provisions	$ 0.8	$ 0.7
Income Tax Examination [Line Items]
Statutory Tax Rate	25.00%	15.00%
Maximum [Member]
Significant Change In Unrecognized Tax Benefits Is Reasonably Possible [Line Items]
Decrease In Unrecognized Tax Benefits Is Reasonably Possible	$ 2.0
Minimum [Member]
Significant Change In Unrecognized Tax Benefits Is Reasonably Possible [Line Items]
Decrease In Unrecognized Tax Benefits Is Reasonably Possible	$ 1.9
Internal Revenue Service (IRS) [Member]
Income Tax Examination [Line Items]
Income Tax Examination Year Under Examination	2012
Foreign Tax Authority [Member] | The Netherlands [Member]
Income Tax Examination [Line Items]
Income Tax Examination Year Under Examination	2010
Income Tax Examination Description	In the fourth quarter of 2015, the Dutch tax authorities assessed the Company’s subsidiary, Quaker Chemical B.V., for additional income taxes related to the 2011 tax year and Quaker Chemical B.V. filed a protest of such assessment.
Foreign Tax Authority [Member] | United Kingdom [Member]
Income Tax Examination [Line Items]
Income Tax Examination Year Under Examination	2010
Foreign Tax Authority [Member] | Brazil [Member]
Income Tax Examination [Line Items]
Income Tax Examination Year Under Examination	2000
Foreign Tax Authority [Member] | Spain [Member]
Income Tax Examination [Line Items]
Income Tax Examination Year Under Examination	2011
Foreign Tax Authority [Member] | China [Member]
Income Tax Examination [Line Items]
Income Tax Examination Year Under Examination	2012
Foreign Tax Authority [Member] | Italy [Member]
Income Tax Examination [Line Items]
Income Tax Examination Year Under Examination	2007
Income Tax Examination Description	The Italian tax authorities have assessed additional tax due from the Company’s subsidiary, Quaker Italia S.r.l., relating to the tax years 2007, 2008, 2009 and 2010. In the first quarter of 2016, the Italian tax authorities delivered an audit report to Quaker Italia S.r.l. for the tax years 2011, 2012 and 2013 alleging additional tax due.
Foreign Tax Authority [Member] | France [Member]
Income Tax Examination [Line Items]
Income Tax Examination Year Under Examination	2008
Income Tax Examination Description	In the first quarter of 2016, the French tax authorities gave notice that they were auditing the Company’s subsidiary, Quaker Chemical S.A.
State and Local Jurisdiction [Member]
Income Tax Examination [Line Items]
Income Tax Examination Year Under Examination	1993

XML

Earnings Per Share - Basic (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Earnings Per Share [Abstract]
Net Income Attributable to Quaker Chemical Corporation	$ 12,946	$ 10,378
Less: Income Allocated to Participating Securities	(113)	(96)
Net Income Available to Common Shareholders	$ 12,833	$ 10,282
Basic Weighted Average Common Shares Outstanding	13,116,807	13,188,761
Basic Earnings Per Common Share	$ 0.98	$ 0.78

XML

Earnings Per Share - Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Earnings Per Share [Abstract]
Net Income Attributable to Quaker Chemical Corporation	$ 12,946	$ 10,378
Less: Income Allocated to Participating Securities	(113)	(96)
Net Income Available to Common Shareholders	$ 12,833	$ 10,282
Basic Weighted Average Common Shares Outstanding	13,116,807	13,188,761
Effect of Dilutive Securities	12,587	19,896
Diluted Weighted Average Common Shares Outstanding	13,129,394	13,208,657
Diluted Earnings per Common Share	$ 0.98	$ 0.78

XML

Earnings Per Share - Antidilutive Shares (Details) - shares	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Earnings Per Share [Abstract]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	11,742	4,497

XML

Goodwill Assets (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2016 USD ($)
Goodwill [Roll Forward]
Goodwill, Beginning Balance	$ 79,111
Goodwill reductions	(153)
Goodwill, Translation Adjustments	1,045
Goodwill, Ending Balance	80,003
North America [Member]
Goodwill [Roll Forward]
Goodwill, Beginning Balance	42,443
Goodwill additions	0
Goodwill, Translation Adjustments	9
Goodwill, Ending Balance	42,452
EMEA [Member]
Goodwill [Roll Forward]
Goodwill, Beginning Balance	19,280
Goodwill reductions	(153)
Goodwill, Translation Adjustments	678
Goodwill, Ending Balance	19,805
Asia Pacific [Member]
Goodwill [Roll Forward]
Goodwill, Beginning Balance	15,244
Goodwill additions	0
Goodwill, Translation Adjustments	165
Goodwill, Ending Balance	15,409
South America [Member]
Goodwill [Roll Forward]
Goodwill, Beginning Balance	2,144
Goodwill additions	0
Goodwill, Translation Adjustments	193
Goodwill, Ending Balance	$ 2,337

XML

Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Finite-Lived Intangible Assets, Gross [Abstract]
Finite-Lived Customer Lists, Gross	$ 68,180	$ 67,435
Finite-Lived Trademarks, Gross	23,533	23,147
Formulations And Product Technology	5,808	5,808
Other Finite-Lived Intangible Assets, Gross	5,869	5,788
Total	103,390	102,178
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Accumulated Amortization	32,026	29,991
Customer Lists [Member]
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Accumulated Amortization	17,030	15,806
Trademarks [Member]
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Accumulated Amortization	6,087	5,538
Formulations And Product Technology [Member]
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Accumulated Amortization	4,128	4,082
Other Intangible Assets [Member]
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Accumulated Amortization	$ 4,781	$ 4,565

XML

Intangible Assets - Amortization (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Goodwill And Intangible Assets Disclosure [Abstract]
Amortization	$ 1,777	$ 1,627

XML

Intangible Assets - Future Amortization (Details) $ in Thousands	Mar. 31, 2016 USD ($)
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract]
For the year ended December 31, 2016	$ 6,895
For the year ended December 31, 2017	6,523
For the year ended December 31, 2018	6,303
For the year ended December 31, 2019	6,201
For the year ended December 31, 2020	5,924
For the year ended December 31, 2021	$ 5,557

XML

Intangible Assets - Finite Lived (Details) - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract]
Indefinite-Lived Trademarks	$ 1.1	$ 1.1

XML

Debt - Narrative (Details) - Line of Credit [Member] - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
Line of Credit Facility Current Borrowing Capacity	$ 300.0
Line of Credit Facility Maximum Borrowing Capacity	$ 400.0
Line Of Credit Maturity Date	Jun. 14, 2018
Line of Credit Facility, Covenant Terms	Access to this credit facility is dependent on meeting certain financial and other covenants, but primarily depends on the Company’s consolidated leverage ratio calculation, which cannot exceed 3.50 to 1.
Line of Credit Facility, Covenant Compliance	At March 31, 2016 and December 31, 2015, the Company’s consolidated leverage ratio was below 1.0 to 1, and the Company was also in compliance with all of the other covenants.
Line of Credit Facility, Amount Outstanding	$ 79.1	$ 62.9

XML

Equity and Noncontrolling Interest (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Beginning Balance	$ 381,243	$ 365,135
Net Income	13,344	10,607
Amounts reported in other comprehensive income (loss)	5,376	(8,535)
Repurchases of common stock	(5,859)	0
Dividends, Common Stock	(4,227)	(4,000)
Share Issuance and Equity-Based Compensation Plans	1,545	1,635
Excess Tax Benefit From Stock Option Exercises	104	287
Ending Balance	391,526	365,129
Common Stock [Member]
Beginning Balance	13,288	13,301
Net Income	0	0
Amounts reported in other comprehensive income (loss)	0	0
Repurchases of common stock	(84)	0
Dividends, Common Stock	0	0
Share Issuance and Equity-Based Compensation Plans	32	31
Excess Tax Benefit From Stock Option Exercises	0	0
Ending Balance	13,236	13,332
Additional Paid-in Capital [Member]
Beginning Balance	106,333	99,056
Net Income	0	0
Amounts reported in other comprehensive income (loss)	0	0
Repurchases of common stock	0	0
Dividends, Common Stock	0	0
Share Issuance and Equity-Based Compensation Plans	1,513	1,604
Excess Tax Benefit From Stock Option Exercises	104	287
Ending Balance	107,950	100,947
Retained Earnings [Member]
Beginning Balance	326,740	299,524
Net Income	12,946	10,378
Amounts reported in other comprehensive income (loss)	0	0
Repurchases of common stock	(5,775)	0
Dividends, Common Stock	(4,227)	(4,000)
Share Issuance and Equity-Based Compensation Plans	0	0
Excess Tax Benefit From Stock Option Exercises	0	0
Ending Balance	329,684	305,902
Accumulated Other Comprehensive Income (Loss) [Member]
Beginning Balance	(73,316)	(54,406)
Net Income	0	0
Amounts reported in other comprehensive income (loss)	5,314	(8,565)
Repurchases of common stock	0	0
Dividends, Common Stock	0	0
Share Issuance and Equity-Based Compensation Plans	0	0
Excess Tax Benefit From Stock Option Exercises	0	0
Ending Balance	(68,002)	(62,971)
Noncontrolling Interest [Member]
Beginning Balance	8,198	7,660
Net Income	398	229
Amounts reported in other comprehensive income (loss)	62	30
Repurchases of common stock	0	0
Dividends, Common Stock	0	0
Share Issuance and Equity-Based Compensation Plans	0	0
Excess Tax Benefit From Stock Option Exercises	0	0
Ending Balance	$ 8,658	$ 7,919

XML

Equity and Noncontrolling Interest - Parentheticals (Details) - $ / shares	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Stockholders Equity [Abstract]
Dividends Declared	$ 0.32	$ 0.3

XML

Equity and Noncontrolling Interest - Reclassifications (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Accumulated Other Comprehensive Loss, Balance at Beginning of Period	$ (73,316)	$ (54,406)
Other Comprehensive Income (Loss) Before Reclassifications	4,386	(8,345)
Amounts Reclassified from AOCI	1,296	717
Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent	5,682	(7,628)
Related Tax Amounts	(368)	(937)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	5,314	(8,565)
Accumulated Other Comprehensive Loss, Balance at End of Period	(68,002)	(62,971)
Accumulated Translation Adjustment [Member]
Accumulated Other Comprehensive Loss, Balance at Beginning of Period	(38,544)	(14,312)
Other Comprehensive Income (Loss) Before Reclassifications	4,671	(11,113)
Amounts Reclassified from AOCI	0	0
Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent	4,671	(11,113)
Related Tax Amounts	0	0
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	4,671	(11,113)
Accumulated Other Comprehensive Loss, Balance at End of Period	(33,873)	(25,425)
Accumulated Defined Benefit Plans Adjustment [Member]
Accumulated Other Comprehensive Loss, Balance at Beginning of Period	(35,251)	(41,551)
Other Comprehensive Income (Loss) Before Reclassifications	(477)	2,498
Amounts Reclassified from AOCI	798	881
Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent	321	3,379
Related Tax Amounts	(134)	(901)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	187	2,478
Accumulated Other Comprehensive Loss, Balance at End of Period	(35,064)	(39,073)
Accumulated Net Unrealized Investment Gain (Loss) [Member]
Accumulated Other Comprehensive Loss, Balance at Beginning of Period	479	1,457
Other Comprehensive Income (Loss) Before Reclassifications	192	270
Amounts Reclassified from AOCI	498	(164)
Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent	690	106
Related Tax Amounts	(234)	(36)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	456	70
Accumulated Other Comprehensive Loss, Balance at End of Period	$ 935	$ 1,527

XML

Equity and Noncontrolling Interest - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Equity Class Of Treasury Stock [Line Items]
Payments For Repurchase Of Common Stock	$ 5,859	$ 0
2015 Share Repurchase Program [Member]
Equity Class Of Treasury Stock [Line Items]
Share Repurchase Program Authorized Amount	$ 100,000
Shares Repurchased And Retired During Period	83,879
Payments For Repurchase Of Common Stock	$ 5,900
Cost of Goods Sold [Member]
Concentration Risk [Line Items]
Reclassification Percentage	30.00%	30.00%
Operating Expenses [Member]
Concentration Risk [Line Items]
Reclassification Percentage	70.00%	70.00%

XML

Business Acquisitions - Table (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Business Acquisition [Line Items]
Finite-Lived Customer Lists, Gross	$ 68,180	$ 67,435
Finite-Lived Trademarks, Gross	23,533	23,147
Other Finite-Lived Intangible Assets, Gross	5,869	5,788
Goodwill	80,003	$ 79,111
Verkol [Member]
Business Acquisition [Line Items]
Current Assets (includes cash acquired)	31,151
Property, Plant & Equipment	7,941
Finite-Lived Customer Lists, Gross	6,146
Finite-Lived Trademarks, Gross	5,378
Other Finite-Lived Intangible Assets, Gross	219
Goodwill	5,012
Other Long-term Assets	158
Total Assets Purchased	56,005
Current Liabilities	(6,681)
Long-Term Debt	(2,400)
Other Long-Term Liabilities	(5,531)
Total Liabilities Assumed	(14,612)
Business Acquisition, Cost of Acquired Entity, Purchase Price, Gross	41,393
Cash Acquired	15,423
Business Acquisition, Cost of Acquired Entity, Purchase Price	$ 25,970

XML

Business Acquisitions - Narrative (Details) $ in Thousands, € in Millions, SEK in Millions	3 Months Ended
	Mar. 31, 2016 USD ($)	Dec. 31, 2015 EUR (€)	Dec. 31, 2015 USD ($)	Sep. 30, 2015 EUR (€)	Sep. 30, 2015 USD ($)	Mar. 31, 2015 SEK	Mar. 31, 2015 USD ($)	Dec. 31, 2014 SEK	Dec. 31, 2014 USD ($)	Sep. 30, 2015 USD ($)
Business Acquisition [Line Items]
Cash Paid for Acquisitions	$ 1,384						$ (528)
Goodwill	$ 80,003		$ 79,111
Binol [Member]
Business Acquisition [Line Items]
Cash Paid for Acquisitions								SEK 136.5	$ 18,500
Post Closing Adjustment						SEK 4.4	$ 500
Verkol [Member]
Business Acquisition [Line Items]
Cash Paid for Acquisitions				€ 37.7	$ 41,400
Long-Term Debt				2.2						$ 2,400
Post Closing Adjustment		€ 1.3	$ 1,400
Cash Acquired				€ 14.1						$ 15,400

XML

Fair Value Measurements - Assets (Details) - Fair Value, Measurements, Recurring [Member] - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Company Owned Life Insurance	$ 1,343	$ 1,336
Assets, Fair Value Disclosure	1,343	1,336
Fair Value, Inputs, Level 1 [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Company Owned Life Insurance	0	0
Assets, Fair Value Disclosure	0	0
Fair Value, Inputs, Level 2 [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Company Owned Life Insurance	1,343	1,336
Assets, Fair Value Disclosure	1,343	1,336
Fair Value, Inputs, Level 3 [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Company Owned Life Insurance	0	0
Assets, Fair Value Disclosure	$ 0	$ 0

XML

Commitments and Contingencies (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Dec. 31, 2015
ACP [Member]
Loss Contingencies [Line Items]
Loss Contingency, Range of Possible Loss, Minimum	$ 0.2
Loss Contingency, Range of Possible Loss, Maximum	0.9
Loss Contingency Accrual At Carrying Value	$ 0.2	$ 0.3
P-2 Well Operation Range Estimate	nine months to thirty three months
SB Decking [Member]
Loss Contingencies [Line Items]
Loss Contingency, Estimate of Possible Loss	$ 3.0
Loss Contingency, Settlement Agreement, Terms	In response, two of the three carriers entered into separate settlement and release agreements with the subsidiary in 2005 and 2007 for $15.0 million and $20.0 million, respectively. The proceeds of both settlements are restricted and can only be used to pay claims and costs of defense associated with the subsidiary’s asbestos litigation. In 2007, the subsidiary and the remaining primary insurance carrier entered into a Claim Handling and Funding Agreement, under which the carrier is paying 27% of defense and indemnity costs incurred by or on behalf of the subsidiary in connection with asbestos bodily injury claims. The agreement continues until terminated and can only be terminated by either party by providing a minimum of two years prior written notice. As of March 31, 2016, no notice of termination has been given under this agreement. At the end of the term of the agreement, the subsidiary may choose to again pursue its claim against this insurer regarding the application of the policy limits.
VAT Total [Member]
Loss Contingencies [Line Items]
Loss Contingency, Range of Possible Loss, Minimum	$ 0.0
Loss Contingency, Range of Possible Loss, Maximum	$ 1.0